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CHAPTER I 
INTRODUCTION 
Lectins have been used in a variety of biological assays to study 
the surface structure and function of cells and tissues. Lectins are 
proteins that are highly specific in their saccharide binding 
requirements as demonstrated by hapten inhibition studies where the 
interactions between lectins and cell surface glycoconjugates can be 
inhibited by simple sugars (Sharon and Lis, 1972). In addition, many 
lectins exhibit differential binding affinities for various mammalian 
cells due to cell-specific differences in the expression of membrane 
glycoconjugates. These properties promote the use of lectins as 
probes to study the structure and activity of cell surface components 
in both normal and pathologically-altered tissues. In biological 
assays, lectins have been used to mimic the functional effects of 
documented, physiological mediators of cellular activity, such as 
hormones, lymphokines and vitamins. Therefore, lectins have been used 
as in vitro model systems to evaluate the mechanisms of cellular 
activation and/or inhibition. 
Although the biological effects of many lectins have been 
investigated on a variety of cellular systems both.!.!!_ vivo and in 
vitro, few studies have used lectins to evaluate the structure and 
1 
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function of the skeletal system. The studies involving the skeletal 
system {Wang et al., 1982; Horton et al., 1982; Ryder et al., 1982) 
indicate that some lectins {i.e. PHA-P and con A) can induce changes 
in the structure and function of bone cells, particularly osteoclasts. 
The osteoclast is a large multinucleate cell that is widely accepted 
as the primary effector cell responsible for normal bone resorption 
{Marks, 1983). Although the definitive origin of the osteoclast 
remains uncertain, there is abundant evidence to support the 
hypothesis that osteoclasts are derived from mononuclear cells of 
hemopoietic origin, possibly of the monocytic lineage {Walker, 1975; 
Marks and Walker, 1981; Schneider and Byrnes, 1983). 
Bone-organ cultures of long bones or calvariae from neonatal 
rodents are model systems used to study the morphological and 
functional effects of biologically active mediators on osteoclastic 
bone resorbing activity. This type of culture system has the 
advantage of correlating changes in morphology with altered functional 
activity as compared to other culture systems in which the cells being 
studied are not on their normal substrate. Reynolds and Dingle {1970) 
reported several advantages in using organ cultures of rodent 
calvariae in comparison to organ cultures of long bones. The 
distribution and numbers of osteoclasts on the inner surface of the 
flat bones of the growing rodent skull are well-documented {Barnicott, 
1947; Abe et al., 1983; Jones and Boyde, 1976 Jones and Boyde, 1977). 
The first part of this dissertation is designed to investigate 
3 
the biological effects of various lectins on bone resorption using a 
calvarial culture system. The remaining studies are designed to 
evaluate possible mechanisms responsible for lectin-induced changes in 
the ability of osteoclasts to resorb bone. Concanavalin A {con A) is 
the most widely used lectin in biological assays and many of its 
properties have been well-documented and thoroughly investigated. 
Other lectins that are frequently used to study the structure and 
function of cells and tissues include wheat germ agglutinin {WGA). 
soybean agglutinin (SBA) and peanut agglutinin (PNA). The saccharide 
binding specificities of these four lectins are distinctly different 
from one another and the sugar residues to which these lectins bind 
are common to mammalian membrane-associated glycoconjugates. 
The four lectins. con A. WGA. SBA and PNA. were used in 
45 
conjunction with a Ca pre-labeled calvarial-organ culture system to 
assess their effects on bone resorption. However. the primary 
emphasis throughout this dissertation focuses on the lectin. con A. 
In the first study. we treated osteoclasts and osteoblasts on the 
endocranial surface of 10-day old rat calvariae with con A and 
hemocyanin to determine whether or not specific con A binding sites 
are present on these bone cell membranes as visualized by scanning 
electron microscopy (SEM). In addition. we conducted a series of 45 ca 
bone release assays using pre-labeled calvariae to evaluate the 
effects of various concentrations of con A on the bone resorbing 
capacity of osteoclasts. After determining the con A-mediated 
4 
effects, we were interested in the effects of the other 3 lectins, 
45 WGA, SBA and PNA, on Ca release in the calvarial culture system. In 
45 the second study, we conducted another series of Ca bone release 
assays using a lectin concentration of 50 pg/ml for each of the 
lectins to be tested. The 50 pg/ml lectin concentration was chosen on 
the basis of the results obtained from the first study. 
The third and fourth studies are designed to gain some insight 
into the mechanisms that may be responsible for lectin induced changes 
in bone resorption and osteoclastic function. Because of the 
difficulty in obtaining pure populations of osteoclasts, most studies 
on bone resorption are performed on intact animals or bone-organ 
cultures. These systems do not permit detailed analysis of the 
cellular mechanisms of bone resorption or of the means whereby 
resorbing cells attach to the bone surface (Teitelbaum et al., 1979). 
Since monocytes and macrophages are capable of attaching to and 
subsequently degrading a bone matrix, the macrophage-devitalized bone 
culture system serves as a useful model to study the mechanisms of 
bone resorption in tissue culture. (Kahn et al., 1978; Teitelbaum et 
al., 1979; Bar-Shavit et al., 1983a). 
In the third study, we used a macrophage-devitalized bone culture 
system to evaluate the effects of 2 lectins, con A and SBA, on the 
morphology of macrophage attaclunent to a devitalized bone surface and 
the subsequent functional ability of these lectin-treated cells to 
mobilize bone mineral. SEM was used to assess the qualitative and 
5 
quantitative differences in the attachment of macrophages to bone in 
the presence and absence of lectin. 45 Furthermore, Ca bone release 
assays were conducted to evaluate the functional significance of the 
morphological findings. 
The induction of many of the functional effects by cell-specific 
mediators of cellular activity (ligands) requires the internalization 
of ligand-receptor complexes subsequent to the binding of a particular 
ligand to specific membrane receptors. The internalization of a 
cell-bound ligand usually includes an initial redistribution followed 
by endocytosis of the ligand-receptor complexes. These 
metabolically-dependent events have been studied in a variety of 
substrate-attached mononuclear cell cultures. Some studies have 
employed the use of biologically active lectins conjugated to 
ultrastructural and cytochemical marker molecules to follow the 
movement of the lectin-receptor complexes both on the cell surface and 
in the cytoplasm. In the fourth study, we investigated the processing 
of con A-receptor complexes by osteoclasts in culture. Con A 
conjugated to fluoresceinisothiocyanate (con A-FITC) was used to 
evaluate the redistribution of cell-bound con A via epifluorescence 
microscopy. In addition, an ultrastructural study using con A-
ferritin was conducted to determine whether these lectin-receptor 
complexes are int~rnalized. The endocytosis of lectin-receptor 
complexes may represent a general mechanism that is used by 
osteoclasts to process other endogenous physiological agents that bind 
6 
directly to the osteoclast membrane thereby regulating osteoclastic 
activity. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Lectins - General Review 
Lectins, the term proposed by Boyd in 1970, are proteins 
possessing the ability to agglutinate red blood cells as well as a 
variety of other cell types. They are isolated from a wide variety of 
sources, ranging from the seeds of plants to the horseshoe crab. 
Besides their agglutinating ability, lectins exhibit a host of other 
interesting biological properties (Lis & Sharon, 1973). Some lectins 
are specific in their reaction with human blood groups and are used in 
the typing of human blood and to study the chemical structure of 
substances defining blood groups. Certain lectins are mitogenic; they 
can stimulate the transformation of small resting lymphocytes into 
large blast-like cells which undergo mitotic division. This 
polyclonal stimulation provides an important tool for examination of 
the biochemical events involved in the conversion of a resting cell 
into an active, dividing cell. Lectins have also been used in 
cytogenetics to study the relationships between chromosome abnormality 
and human diseases. 
Lectins bind to specific saccharides on the cell surface, 
providing a useful tool to study cell surface architecture. Lectins 
7 
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specifically precipitate polysaccharides and glycoproteins, a property 
useful in the isolation and purification of carbohydrate-containing 
polymers (Sharon & Lis, 1972). By virtue of their specific 
interactions with polysaccharides and glycoproteins, they have served 
as a useful model to study the antigen-antibody reaction. There has 
been a surge of interest in lectins among investigators engaged in 
cancer research. Some lectins, such as con A, WGA and SBA, 
preferentially agglutinate transformed mammalian cells grown in tissue 
culture, indicating that the cell surface of a transformed cell 
differs significantly from the surface of its untransformed 
counterpart (Inbar & Sachs, 1969a; Inbar & Sachs, 1969b; Burger & 
Goldberg, 1967; Sela et al., 1970). The use of lectins to inhibit the 
growth of malignant cells in vivo and in vitro (Burger & Noonan, 1970; 
Shoham et al., 1970), and the use of lectin-binding synthetic polymers 
to immunize mice against various tumors (Shier, 1971), are examples of 
the potential clinical usefulness of lectins in oncology. Recently, 
lectin histochemistry has been used in developmental biology to 
evaluate changes in cell surface glycoconjugates during the 
development of various tissues and organ systems (Wu et al., 1983; Lee 
and Damjanov, 1984; Farnum and Wilsman, 1984; Wu et al., 1984). 
Green et al. (1981) and Fleisher et al. (1981) have shown that 
con A-activated peripheral blood mononuclear cells produce a soluble 
immune suppressor supernatant (SISS) which contains certain factors 
that are capable of suppressing immune responses in vitro. Barrett et 
9 
al. {1983) reported that WGA could inhibit lymphocyte blastogenesis, 
induced by a variety of mitogenic lectins. Thus, WGA-mediated 
inhibition of mitogenesis was found to mimic the suppressive effect of 
SISS on lymphocyte blastogenesis. They also demonstrated that the 
inhibition of mitogenesis induced by either WGA or SISS could be 
blocked by the addition of N-acetylgalactosamine, the specific sugar 
inhibitor of WGA binding. Furthermore, WGA and SISS compete with one 
another for the same cell surface receptor site. These findings 
support the hypothesis that inhibitory or suppressive signals for 
lymphocyte activation can be generated by the binding of soluble 
saccharide-specific factors that interact with cell surface 
glycoconjugates {Green et al., 1981; Fleisher et al., 1981). A study 
by Leu et al. {1980) compared a lectin, fucose binding protein {FBP), 
with a lymphokine, migration inhibitory factor {MIF), for its binding 
interactions with peritoneal macrophages using a migration inhibition 
assay. Their results demonstrated that both FBP and MIF inhibited the 
migration of macrophages in similar dose-response profiles. In 
addition, L-fucose, the specific sugar inhibitor of FBP, blocked the 
inhibitory effect of both FBP and MIF on macrophage migration. 
Therefore, the interaction of exogenous lectins or endogenous 
-
lymphokines with saccharide-associated cell surface receptors may 
represent a common mechanism by which soluble factors regulate 
innunological responses. All of these studies provide evidence to 
substantiate the use of certain lectins as in vitro models for 
10 
saccharide-specific, biologically relevant mediators of cellular 
activity. This conclusion lends some additional credibility to the 
possibility that lectin-induced changes in cellular morphology and 
function, may mimic the effects of well-documented, physiological 
agents that regulate the strucutre and function of cells in vivo. 
The study of lectins was initiated by Stillmark in 1888, when he 
described the agglutination of erythrocytes by plant extracts. He 
found that castor beans contained a toxic protein, which he named 
ricin, capable of agglutinating both human and animal red blood cells. 
Ehrlich used ricin to study and describe a fundamental principle of 
immunology. In 1891, he reported that mice could be immunized against 
a lethal dose of ricin by repeated subcutaneous injections of minute 
amounts of the toxin, and that the serum of these immunized mice was 
capable of neutralizing the toxin. In 1908, Landsteiner and 
Raubitschek demonstrated that various seed extracts exhibited 
differential agglutinating activities when tested with erythrocytes 
from different animals, and they compared this specificity with that 
of animal serum antibodies. Although it was originally presumed that 
plant hemagglutinins were non-specific with respect to blood groups, 
these initial observations by Landsteiner and Raubitschek (1908) led 
to the discovery that certain lectins are specific for one or more 
human blood group antigens (Boyd & Reguera, 1949). 
Most of the initial studies using lectins were conducted using 
crude extracts of plant origin. Although the first purified lectin, 
11 
concanavalin A, was obtained in crystalline form from the jack bean by 
Sumner as early as 19i9, it was not until 1936 that Sumner and Howell 
showed that purified con A agglutinated horse red blood cells at 
concentrations as low as O.l_µg/ml, thus linking the agglutinating 
activity of the jack bean extract with con A. Since then, con A has 
become the most widely used lectin in biological assays. Other 
lectins which have been widely used to study the structure and 
function of various cellular systems include WGA, SBA and, more 
recently, PNA. These three lectins have also been isolated in 
purified form and their chemical composition determined. 
Lectins are highly specific in their cell surface saccharide 
binding requirements. This conclusion is based on hapten inhibition 
studies which demonstrate that the interactions of lectins with cells 
can be specifically inhibited by simple sugars. Some lectins 
discriminate between 0(- and ~-anomers of a particular sugar residue, 
while others bind to both the d..- and ~-anomeric structures with equal 
affinity. Some lectins require that the binding sugar be located in a 
terminal non-reducing position in the oligosaccharide chain, while 
others can bind to sugars within the oligosaccharide chain. The 
affinity between a lectin and its binding site can exhibit a great 
deal of variation due to small changes in the sequence of sugars 
within an oligosaccharide. Because of the binding specificity that 
each lectin has for a particular carbohydrate structure, even 
oligosaccharides with identical sugar compositions can be separated 
12 
and distinguished from one another. 
Most lectins that have been isolated and analyzed to date are 
composed of multiple subunits, which are held together by non-covalent 
bonds. These subunits are polypeptide chains that usually contain 
covalently bound carbohydrate side chains. Con A, WGA, SBA and PNA 
are multimeric lectins; con A and PNA are each composed of 4 identical 
subunits, whereas WGA and SBA are each composed of 2 identical 
subunits. SBA and PNA are glycoproteins, and the sugars which have 
been isolated from these lectins are common to animal cell membranes. 
In contrast, con A and WGA are devoid of covalently bound carbohydrate 
side chains. It is the multimeric structure of lectins that allows 
them to agglutinate cells and form precipitates with glycoconjugates 
in a manner similar to antigen-antibody interactions. Although most 
lectins can bind to a variety of different cell types, agglutination 
of cells occurs only in some cell types. On the other hand, some 
lectins do not bind to particular cell types, which is probably due to 
the absence or masking of the suitable receptor oligosaccharides on 
the cell surface. 
The sugar specificities of con A, WGA, SBA and PNA are distinctly 
different from one another. All of the sugar residues to which these 
lectins bind are common to many mammalian membrane-associated 
glycoconjugates. Con A has a broad biological applicability primarily 
because it recognizes 2 commonly occurring cell surface saccharides, 
o(-D-mannose and D<-D-glucose. Although it was originally postulated 
13 
that the specificity of con A is directed toward a single sugar 
residue, studies by So et al. (1968) demonstrated that o(-linked 
mannose disaccharides and trisaccharides are stronger inhibitors of 
the con A-dextran interaction by 5 and 20 times respectively, than is 
~-methylmannoside, the haptenic sugar inhibitor of con A binding. 
These results suggest that the con A binding site is more complex in 
both its primary structure and three-dimensional configuration than 
originally proposed. WGA can bind oligosaccharides containing 
terminal N-acetylglucosamine (GluNAc) residues, with preferential 
binding to dimers and trimers of this saccharide. SBA preferentially 
binds to oligosaccharides with terminal ~- or P-linked 
N-acetylgalactosamine (GalNAc) residues, and to a lesser extent to 
D-galactose residues. PNA binding is directed toward D-galactose 
residues, although this lectin binds to the disaccharide, galactosyl 
G-1,3 GalNAc, with greatest affinity. This dissacharide is called the 
T-antigen, and its presence on the surface of human erythrocytes is 
responsible for a phenomenon known as T-polyagglutination, a problem 
encountered in routine serology. T-polyagglutination, the 
agglutination of red blood cells irrespective of blood type, is caused 
as a result of in vitro contamination of blood specimens by the 
degradative action of bacterial neuraminidase which exposes the 
T determinant (Goldstein & Hayes, 1978). The discovery of PNA has 
greatly simplified the determination of T-polyagglutination in blood 
specimens. 
14 
processing of Concanavalin A 
Since con A is the most widely used lectin in biological assays, 
it has been used extensively as a probe to study cell surface 
interactions. The various biological activities of con A all appear 
to involve initial binding of con A to the cell surface. The manner 
in which cells process this cell-bound lectin has been the focus of a 
great number of investigations. Although various cell types have been 
used in these studies, most of the observations have been made using 
lymphocytes, since it is well documented that con A is mitogenic for 
lymphocytes. Taylor et al. (1971) demonstrated cap formation of 
surface immunoglobulin (lg) determinants on mouse lymphocytes induced 
by the interaction of FITC-labeled anti-lg antibodies with the lg 
molecules of the cell membrane. Following capping, the surface lg 
determinants were pinocytosed. Since this initial discovery, 
antibody-induced patch and cap formation has been described in various 
cell types. In 1972, Yahara and Edelman reported that con A prevents 
anti-lg patch and cap formation, presumably by restricting the 
mobility of cell surface lg determinants. Karnovsky and Unanue (1973) 
reported that the redistribution of con A receptors, induced by the 
binding of con A, did not alter the distribution of surface lg 
molecules and vice versa. These findings indicate that the inhibition 
of patching and capping by con A cannot be attributed to the linkage 
of mobile receptors to immobile con A receptors by con A, nor to 
15 
extensive cross-linkage of various specific receptors by con A. 
Gunther et al. (1973) observed that divalent succinylated con A cannot 
inhibit receptor mobility although it directly competes with its 
non-derivatized counterpart for the same binding sites. These 
observations suggest that the binding valency of the lectin is an 
important factor in the inhibition of receptor mobility and the 
cross-linkage of receptor molecules is a necessary condition for 
inhibition of receptor mobility. 
In contrast to its inhibitory effects on patch and cap formation, 
con A has been shown/to induce patching and capping of its own binding 
sites under certain conditions of incubation. Unanue et al. (1972) 
used FITC-con A to demonstrate that patching and capping of con A 
binding sites occurred when lymphocytes were labeled with con A at 
0 4 C, then washed to remove unattached con A molecules, followed by 
incubation at 37°c. Yahara and Edelman (1973) showed that lymphocytes 
incubated at 37°c in concentrations of con A above 10 )Jg/ml did not 
exhibit patch or cap formation, whereas at concentrations below 
10 pg/ml capping of con A binding sites occurred in a small percentage 
of cells. In contrast to the findings observed at 37°c, when 
0 lymphocytes were pre-incubated with con A at 4 C, then washed to 
0 
remove excess con A and incubated at 37 C, patch and cap formation was 
observed in a large percentage of lymphocytes regardless of the 
concentration of con A. These observations were confirmed by Bhalla 
et al. (1979) who demonstrated that if washing is omitted after 
16 
0 pre-incubation at 4 C or if con A is added again after washing, the 
0 percentage of cells forming caps at 37 C is drastically reduced. 
These results indicate that depending on the conditions of incubation 
employed, con A exhibits 2 antagonistic properties when bound to 
lymphocytes. Con A exhibits the ability to induce cap formation of 
its own binding sites and it can also inhibit the redistribution of 
ligand-receptor complexes including that of its own. 
Since it has been postulated that some of the biological effects 
of con A initiated at the cell surface may be a result of its multiple 
binding valency, it is necessary to compare the effects of different 
forms of this molecule, each having the same binding specificity but 
different valence. Wang and Edelman (1978) reported the preparation 
and characterization of monovalent, divalent and tetravalent con A 
molecules that are stable at physiological pH. They demonstrated that 
all three derivatives were potent mitogens for mouse splenic 
lymphocytes suggesting that multipoint attachment and cell surface 
receptor bridging are not necessary for lymphocyte activation. In 
contrast, at concentrations above the mitogenic optimum, only 
tetravalent con A was capable of inhibiting both cap formation and 
cell proliferation. These results indicate that the inhibition of 
binding site mobility and DNA synthesis does require extensive 
cross-linkage of con A binding sites. The observations made in this 
study can explain the inconsistent observations of Greaves et al. 
(1972) and Sallstrom et al. (1972), who reported that a large 
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0 percentage of lymphocytes incubated at 37 C in high concentrations of 
con A exhibited patch and cap formation. It has been shown that the 
fluorescein-labeled con A molecules used by these investigators were 
irreversibly denatured, and therefore, these molecules were either 
monovalent or divalent derivatives. The observations that con A can 
bind to various molecules that do not contain any saccharide residues 
in their structure led to the identification of a hydrophobic binding 
site within the con A molecule that is distinct from and independent 
of its saccharide binding site (Edelman & Wang, 1978). After con A 
binds to the cell surface via its saccharide binding site it is 
capable of interacting with hydrophobic ligands; this secondary 
interaction may induce surface alterations necessary for some of the 
biological effects mediated by this lectin. 
Although cross-linkage of receptor sites can partially account 
for the ability of con A to inhibit the redistribution of 
ligand-receptor complexes including that of its own, this event does 
not account for the difference in the number of cap forming cells 
0 following pre-incubation at 4 C as compared to cells incubated at 
37°C. It is well known that antimitotic agents, such as colchicine 
and vinblastine, or incubation in cold (4°C) will cause the disruption 
of microtubules. Numerous studies have demonstrated that microtubule 
disassembly is directly correlated with enhanced con A cap formation 
on lymphocytes and other cell types (Edelman et al., 1973; Unanue & 
Karnovsky, 1974; Oliver, 1976; Bhalla et al., 1979; Oliver et al., 
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19so). These observations suggest a role for microtubules in limiting 
the lateral movement of con A-binding site complexes within the 
membrane. Edelmen et al. (1973) have proposed an hypothesis that 
relates con A-mediated cell surface events to colchicine-sensitive 
binding proteins (CBP) in the cytoplasm. These proteins may either be 
the components of microtubules or be closely related to micotubular 
proteins. They suggest that con A binding sites may occur in 2 
states; free (not attached to CBP) or attached (anchored to CBP). 
Thus, the treatment of cells with an agent that disrupts microtubules 
allows greater mobility because the equilibrium between these two 
receptor states shifts greatly in favor of the free receptors. This 
hypothesis provides an explanation for the increase in con A-induced 
0 
cap formation observed when cells are pre-labeled at 4 C or treated 
with a microtubular poison. 
Microfilaments have also been implicated in lectin-mediated cell 
surface activation. Studies have demonstrated that the aggregation of 
con A-binding site complexes into caps can be prevented by metabolic 
inhibitors and by agents, such as cytochalasin B, that impair 
microfilament function (Ryan et al., 1974; dePetris, 1975; Schreiner & 
Unanue, 1976). Condeelis (1979) isolated con A cap-associated 
membrane fragments at various stages of formation and demonstrated a 
submembranous network of microfilaments in association with these 
capped membrane fragments. These studies support the hypothesis that 
con A patch and cap formation depends on active contractile movements 
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of microfilaments. Although con A caps are underlain by a dense 
network of microfilaments in lymphocytes and other cell types, 
Albertini et al. (1977) demonstrated that the accumulation of 
microfilaments in the region of the eventual site of con A cap 
formation is not induced by con A. Instead, they showed that the 
accumulation of microfilaments follows the disruption of microtubules. 
Their results indicate that the aggregation of microfilaments and 
con A cap formation are independent events. Once the cap is formed, 
interactions between con A-binding site complexes and microfilaments 
appear to stabilize the localization of both the surface-bound lectin 
and the submembranous network of microfilaments. The subsequent 
internalization of con A-binding site complexes is a metabolically 
dependent event (Smith & Hollers, 1970), and it is believed that the 
interaction between surface-bound lectin and underlying microfilaments 
is necessary for the endocytosis of these complexes. Once con A has 
been internalized there are several possible mechanisms by which the 
lectin can mediate some of its biological effects. 
Biological Effects of Lectins on the Skeletal System 
The great number of studies examining con A binding and 
subsequent processing by lymphocytes have provided hypotheses that 
attempt to explain the mechanisms by which lectins interact with cell 
surfaces, thereby altering the structure and activity of membrane 
components. Aside from the mechanisms which account for lectin-cell 
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surface interactions, the biological effects of many lectins on a 
variety of cellular systems have been investigated both in vivo and in 
vitro. However, only a few studies have used lectins as probes to 
~
investigate their effects on the structure and function of the 
skeletal system. Wang et al. (1982) studied the effects of PHA-P, a 
mitogen known to selectively stimulate cells of hematogenous or 
lymphoid monocytic origin, on bone of the growing rat. They 
demonstrated that the in vivo administration of PHA-P for 15 days 
caused a reduction in the number of osteoblasts, whereas the number of 
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osteoclasts, the number of H-labeled osteoclastic nuclei and the 
average number of nuclei per osteoclast were all significantly 
increased. They suggest that the increase in the number and size of 
osteoclasts following in vivo administration of PHA-P is caused by 
PHA-P induced osteoclast progenitor cell proliferation and the 
enhanced fusion and differentiation of these progenitor cells into 
osteoclasts. 45 Horton et al. (1982) in their Ca bone release assays, 
demonstrated a decrease in resorption of long bones cultured in the 
presence of high concentrations of con A (50 & 100 µg/ml). Subsequent 
TEM of osteoclasts incubated in 50 µg/ml con A revealed 
ultrastructural changes associated with inhibition of osteoclastic 
activity (Ryder et al., 1982). 
The studies involving the skeletal system indicate that some 
lectins can induce changes in the structure and function of bone 
cells, particularly osteoclasts. Thus, lectins may prove to be useful 
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probes to study changes in osteoclast morphology in relation to 
changes in their bone resorbing activity. Organ culture of calvaria 
provides an ideal system for studying the effects of lectins on the 
structure and function of resident osteoclasts on their normal 
substrate. The endosteal surface represents an easily accessible site 
to study cell surface receptors on osteoclasts as well as changes in 
osteoclast morphology as visualized by both SEM and TEM. SEM can be 
used to study changes in cell surface morphology, whereas TEM can be 
used to investigate both surface and cytoplasmic changes within the 
osteoclast. 45 Calvaria pre-labeled with Ca can be used to study the 
effects of lectins on bone resorption in vitro. 
Biology of the Osteoclast 
The osteoclast is a large multinucleate cell that is widely 
accepted as the primary effector cell responsible for bone resorption 
(Marks, 1983). Ultrastructural changes associated with hormonal 
regulation of osteoclastic activity have been well documented both in 
vivo (Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman 
et al., 1979). Recently, various morphological changes of inhibited 
osteoclasts cultured in the presence of calcitonin and prostacyclin 
have been described using phase contrast microscopy (Chambers & Dunn, 
1982; Chambers & Magnus, 1982; Chambers & Moore, 1983). Similarly, 
morphological characteristics of presumably active or inhibited 
osteoclasts, as visualized by SEM, have been described both in situ 
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(Jones & Boyde, 1977) and~ vitro (Allen et al., 1981). Despite all 
of the observed morphological changes associated with various known 
mediators of osteoclastic activity, little is known about the 
mechanisms by which these hormones exert their effects. 
Recently, numerous investigators have probed the osteoclast 
membrane to determine whether or not specific receptors for 
parathyroid hormone (PTH) and calcitonin (CT), the two primary 
hormones regulating osteoclastic function, are present. In an in vivo 
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study utilizing I-calcitonin, localization of calcitonin receptors 
on the osteoclast membrane has been demonstrated (Warshawsky et al., 
1980). Calcitonin receptors have also been demonstrated on 
osteoclasts by immunohistochemical staining (Rao et al., 1981). 
Chambers and Magnus (1982) confirmed the localization of CT receptors 
on osteoclasts by demonstrating that calcitonin causes complete 
inhibition of cytoplasmic motility in isolated osteoclasts in vitro. 
In contrast, light microscopic autoradiographs of chick embryonic 
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calvaria after exposure to I-parathyroid hormone (PTH; 1-34) have 
revealed PTH receptors on osteoblasts, but not osteoclasts (Silve et 
al., 1982). The lack of PTH receptors on osteoclasts is also 
supported by the recent findings of Chambers and Dunn (1982); the 
addition of PTH to cultures of isolated osteoclasts caused no change 
in their behavior or morphology. Similarly, PTH added to isolated 
osteoclasts that were previously inhibited by CT did not oppose the 
morphological inhibitory changes induced by calcitonin (Chambers & 
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Moore, 1983). These results support the hypothesis that some hormones 
may act directly on osteoclasts (i.e. CT), while others may regulate 
osteoclastic activity indirectly (i.e. PTH) through the intermediary 
of another cell type (Chambers & Dunn, 1983). 
Besides PTH and CT, several studies have identified other 
hormones and biologically active molecules that can mediate bone 
resorption in vitro. The mechanism by which mitogenic lectins 
stimulate lymphocyte production of osteoclast activating factor (OAF) 
has been well documented (Horton et al., 1972; Horton et al., 1974; 
Trummel et al., 1975; Yoneda et al., 1979). Horton et al. (1974) 
showed that OAF production by lymphocytes depends on an interaction 
between macrophages and lymphocytes. The release of OAF by 
lymphocytes stimulates osteoclastic activity resulting in an increased 
resorption of bone. Gowen et al. (1983) demonstrated that the 
monokine, interleukin 1, stimulates bone resorption in vitro. Klein 
and Raisz (1970) demonstrated that the effects of several 
prostaglandins on bone resorption were similar to those of PTH in 
stimulating the resorption of fetal long bones in vitro. In 1972, 
Raisz et al. showed that l~,25 dihydroxyvitamin n3 (l~,25(0H) 2n3 ) is a 
potent stimulator for the release of previously incorporated 45ca from 
fetal long bones in culture. Nimberg et al. (1981) recently purified 
and characterized a glycoprotein from cancer ascites fluid which 
stimulates the resorption of bone explants in vitro. These findings 
suggest that the localized osteolysis seen in patients with a wide 
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variety of neoplasms may be mediated by bone-resorbing humoral 
factors. Chambers and Dunn (1983) showed that the addition of PGE 2 or 
l~,25(0H) 2n3 to cultures of isolated osteoclasts caused no change in 
their behavior or morphology. Since numerous investigators have 
observed that prostaglandins and l«,25(0H) 2n3 have a variety of 
effects on osteoblasts, a role for osteoblasts in the hormonal control 
of bone resorption has been postulated (Rodan & Martin, 1981). 
The hypothesis that the osteoclast precursor is extraskeletal in 
origin has been recently accepted (Marks, 1983). Although the 
definitive origin of the osteoclast remains uncertain, there is 
abundant evidence to support the hypothesis that osteoclasts are 
derived from mononuclear cells of hemopoietic origin, possibly of the 
monocytic lineage (Walker, 1975; Harks and Walker, 1981; Schneider and 
Byrnes, 1983). This hypothesis has created an extensive investigation 
to determine if these 2 distinct cell types share a common lineage. 
Studies have focused on both structural and functional similarities 
between these two cell types. 
Some investigators have studied the cell surface of both 
osteoclasts and macrophage mononuclear cells to determine whether or 
not certain receptor sites known to exist on macrophages can also be 
demonstrated on osteoclasts and vice versa. The findings of one study 
supporting the presence of common membrane determinants in these two 
cell types, indicated that elicited peritoneal mononuclear phagocytes 
possess functional receptors for both PTH and CT (Minkin et al., 
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1977). In contrast, although Fe and C3 receptors are normally present 
on macrophages, no one has been able to demonstrate these receptors on 
osteoclasts either in situ (Shapiro et al., 1979; Hogg et al., 1979) 
or_!!!. vitro (Chambers, 1979). Other studies have focused on 
functional similarities between the osteoclast and the macrophage 
mononuclear cell. Martini et al. (1982) used an in vitro assay to 
quantitate the attachment of osteoclasts and monocytes to developing 
bone. Their results demonstrated that twice as many osteoclasts and 
monocytes adhere to bone as compared to fibroblasts or mesenchymal 
cells. These observations suggest that osteoclasts and monocytes have 
a higher affinity for bone than cells that are unrelated to a bone 
substrate. Zallone et al. (1983) demonstrated that osteoclasts and 
monocytes exhibit similarities in their intracellular organization of 
cytoskeletal elements and adhesive properties in vitro. 
Macrophage Mediated Bone Degradation 
In addition to the many studies which have attempted to establish 
a common lineage between the osteoclast and the macrophage mononuclear 
cell, it has been well-documented that cells of the mononuclear 
phagocyte system are capable of resorbing devitalized bone in vitro 
(Mundy et al., 1977; Kahn et al., 1978; Teitelbaum et al., 1979). 
Kahn et al. (1978) demonstrated that peripheral blood monocytes are 
capable of resorbing devitalized bone in culture and that an important 
component of this process involves the attachment of the monocytes to 
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the bone matrix. Teitelbaum et al. (1979) developed an experimental 
system in which bone resorption by mononuclear cells can be precisely 
3 45 quantitated via the release of either H-proline or Ca from 
pre-labeled bone. Their results also indicated that optimal 
mobilization of the radioactive label by mononuclear cells requires 
cell-matrix contact. In contrast to these findings, Mundy et al. 
(1977) reported that physical contact between peripheral blood 
monocytes and bone in tissue culture was not a necessary condition for 
the release of bone mineral and matrix. 
Glowacki et al. (1981) recently developed a model system in which 
they implanted devitalized bone fragments into calvarial defects in 
rats. These implants initiated a rapid cell-mediated resorptive 
sequence. A histological and ultrastructural study of these implants 
by Holtrop et al. (1982) demonstrated that the cells surrounding the 
bone fragments belong to the mononuclear phagocyte system. However, 
none of these cells, even the multinucleate giant cells, had ruffled 
borders, a morphological hallmark of osteoclasts, and therefore, could 
not be classified as osteoclasts. Other studies have also 
demonstrated that macrophages attached to bone acquire a number of the 
morphological characteristics of osteoclasts in culture, with the 
exception of ruffled borders (Kahn et al., 1978; Rifkin et al., 1979). 
Severson (1983) took mononuclear cells isolated from the spleen or 
bone marrow of young rats and injected them into diffusion chambers 
containing devitalized bone fragments. She reported that these 
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mononuclear cells differentiated into osteoclast-like cells as 
visualized by light microscopy (LH) and SEM. All of these 
observations support the hypothesis that bone resorption in vivo 
involves the participation of macrophages in conjunction with the 
action of osteoclasts (Heersche, 1978). 
Since the degradation of mineralized bone matrix .!E_ vivo is 
primarily a function of mutinucleated osteoclasts which are derived 
from mononuclear precursors, investigators have studied whether or not 
the attainment of the multinucleated state has any effect on the 
ability to attach to bone and subsequently degrade this matrix. The 
fusion of macrophages in vitro has been induced by treating macrophage 
cultures with conditioned media obtained from con A-stimulated 
lymphocytes (Sone et al., 1981) and from spleen cell cultures treated 
with PHA, con A or l-<,25(0H) 2n3 (Abe et al., 1983). In addition, 
l~,25(0H) 2n3 added directly to macrophage cultures will also induce 
fusion. Bar-Shavit et al. (1983a) showed that laC,25(0H) 2D3 elicits 
monocytic differentiation and multinucleation in human promyelocytic 
leukemia HL-60 cells, and that this transformation is accompanied by a 
marked increase in the ability of these cells to bind and resorb bone. 
Fallon et al. (1983) produced macrophage polykaryons by exposing 
elicited macrophages to human serum. These macrophage polykaryons and 
their mononuclear precursors were assessed for their ability to 
degrade 45ca-labeled, devitalized bone in vitro. The results 
demonstrate that macrophage polykaryons exhibit a greater resorptive 
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potential suggesting that the formation of multinucleated cells from 
mononuclear precursors is a physiologically significant event. 
CHAPTER III 
ULTRASTRUCTURAL LOCALIZATION OF CONCANAVALIN-A 
BINDING SITES ON BONE CELLS: EFFECTS OF 
CON A ON OSTEOCLASTIC BONE RESORPTION 
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ABSTRACT 
When osteoclasts on the endocranial surface of 10-day old rat 
calvaria are treated with concanavalin-A and hemocyanin, con A binding 
sites can be visualized by scanning electron microscopy {SEM). The 
hemocyanin label was uniformly distributed on the dorsal {unapposed) 
surface of all osteoclasts observed by SEM; it could be visualized on 
smooth surfaces, microvillous projections and filopodia. Osteoblasts 
were also labeled with the hemocyanin marker, demonstrating con A 
binding sites. 45 ca bone release assays of prelabeled calvaria 
incubated in varying concentrations of con A were conducted to 
determine whether or not con A has any functional effects on 
osteoclasts. At low concentrations of con A {0.1 pg/ml), there was an 
increase in bone resorption at 24, 48 and 72 hours of incubation. In 
contrast, calvaria incubated in high concentrations of con A {50 pg/ml 
and 100 pg/ml) showed a marked decrease in bone resorption 
significantly different from that of controls {incubated without the 
addition of con A) at each of the three 24 hour time periods. These 
45 differences in the release of Ca may indicate direct, dose-dependent 
effects of con A on osteoclastic bone resorption. 
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INTRODUCTION 
The osteoclast is a large multinucleate cell which is widely 
accepted as the primary effector cell responsible for bone resorption. 
Although the ultrastructural changes associated with various hormones 
which regulate osteoclastic activity have been well documented 
(Wezeman et al., 1979; Holtrop et al., 1979), little is known about 
the mechanisms by which these hormones exert their effect. Recently, 
investigators have probed the osteoclastic membrane to determine 
whether or not specific receptors for parathyroid hormone (PTH) and 
calcitonin (CT), the two primary hormones regulating osteoclastic 
function, are present. The results suggest that some hormones may act 
directly on osteoclasts (i.e. CT), while others may regulate 
osteoclastic activity indirectly (i.e. PTH) through the intermediary 
of another cell type (Warshawsky et al., 1980; Rao et al., 1981; Silve 
et al., 1982; Chambers and Dunn, 1982). 
The hypothesis that the osteoclast precursor is extraskeletal in 
origin has been recently accepted (Marks, 1983). Although the 
definitive origin of the osteoclast remains uncertain, there is 
abundant evidence to support the hypothesis that osteoclasts are 
derived from mononuclear phagocytes {Marks, 1983). Some of the 
studies to determine whether the osteoclast and the macrophage share a 
common lineage have focused on the similarities and differences of 
cell surface receptors on these two distinct cell types. Recently, 
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attempts to demonstrate Fe and C3 receptor sites on osteoclasts, which 
are characteristically present on macrophages, have been unsuccessful 
(Shapiro et al., 1979; Chambers, 1979; Hogg et al., 1980). 
In addition to studies dealing with highly specific receptors, 
lectins have been used as a more general probe to study both cell 
surface characteristics and functions. Horton et al. (1982) in their 
45 ca bone release assays, demonstrated a decrease in resorption of 
long bones cultured in the presence of high concentrations of con A 
(50 pg/ml and 100 pg/ml). Subsequent transmission electron microscopy 
(TEM) of osteoclasts incubated in 50 pg/ml con A revealed 
ultrastuctural changes associated with inhibition of osteoclastic 
acitivity (Ryder et al., 1982). We therefore treated osteoclasts on 
the inner surface of 10-day old rat calvaria with con A and hemocyanin 
to determine whether or not specific con A binding sites were present 
on the osteoclast membrane. 45 Furthermore, we incubated Ca prelabeled 
calvaria in varying concentrations of con A to evaluate the functional 
significance of our morphological findings which verified the 
existence of specific con A binding sites on osteoclasts. 
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MATERIALS & METHODS 
Cell Surface Labeling 
Removal of Calvaria - Twelve 10-day old Norway Hooded rats were 
anesthetized with ether and sacrificed prior to removal of their 
calvaria. The calvaria were incubated in Hanks' Balanced Salt 
Solution (HBSS) for 30 minutes. The soft tissue was dissected off the 
endocranial surface and the calvaria were rinsed twice in phosphate 
buffered saline (PBS). Eight calvaria were used for 
concanavalin-A-hemocyanin labeling and four were prepared for a 
conventional SEM image. 
Concanavalin-A-Hemocyanin Labeling - The labeling procedure 
employed was similar to that used by Schneider et al. (1979) for 
lymphocytes. Eight calvaria were pre-fixed in 1.0% glutaraldehyde in 
O.lM Na cacodylate buffer. The samples were incubated in O.lM 
0 
ammonium chloride in cacodylate for 8 hours at 4 C, which blocks any 
aldehydes on the cell surface that may cause non-specific hemocyanin 
labeling. The calvaria were then rinsed in cacodylate buffer and 
incubated in 100 pg/ml concanavalin-A (con A) (Polysciences, 
0 Warrington, Pa.) for 10 minutes at 37 C. This is the natural 
tetravalent form of con A. In all of the following studies it was 
used under the appropriate pH and ionic conditions to remain in its 
tetravalent form. After the con A treatment, one half of the calvaria 
were incubated in 0.05M «-methyl mannoside (Polysciences, Warrington, 
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pa.), a haptenic inhibitor of con A binding, and used as controls to 
demonstrate the specificity of hemocyanin labeling. Both con A 
treated and control calvaria were then rinsed and incubated in 
1.0 mg/ml hemocyanin (Polysciences, Warrington, Pa.) for 10 minutes at 
37°c, followed by another rinse in cacodylate buffer. The hemocyanin 
was first passed through a 0.45 pm Millipore filter to avoid 
aggregates which can obscure cell surface morphology. 
Conventional SEM Tissue Preparation - After the labeling 
procedure, all twelve calvaria were incubated in 2.5% glutaraldehyde 
in O.lM cacodylate for l hour and post-fixed in 1.0% osmium tetroxide 
in O.lM cacodylate for l hour at 4°C. Following fixation the calvaria 
were rinsed in cacodylate and dehydrated through a graded series of 
ethanol. They were then critical point dried via co2 using a Denton 
DCP-1 (Denton Vacuum, Cherry Hill, N.J.). After drying, the specimens 
• 
were attached to aluminum stubs and coated (200A thickness) with 
Gold/Palladium using a Hummer II sputter-coating apparatus (Technics, 
Alexandria, Va.). The specimens were scanned using an ETEC Autoscan 
0 (Hayward, Ca.) at an accelerating voltage of 20kV and a 45 tilt. 
~a Bone Release Assay 
The calvaria of twelve 7-day old Norway Hooded rats were 
pre-labeled by injecting the animals with 40 µCi of 45ca per rat 
(specific activity 10-40 mCi/mg calcium, Amersham, Arlington Heights, 
Il.). Three days later, the animals were anesthetized with ether and 
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sacrificed. The calvaria were removed under sterile conditions and 
placed into HBSS. The dura mater and periosteum were dissected off 
the endocranial surface and the calvaria were rinsed in HBSS. Each 
calvarium was split longitudinally down the sagittal suture, and 
corresponding halves were placed into adjacent wells of a 24-well 
costar tissue culture cluster. Each well contained 2 ml of BGJb media 
supplemented with 5% Fetal Bovine Serum, 100 units/ml Penicillin-
Streptomycin, and 0.292 mg/ml Glutamine. The calvarial halves were 
incubated at 37°C for 24 hours in 5% co2 and air to remove the labile 
45
ca. After 24 hours, the media was discarded and the wells were 
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rinsed with HBSS to remove any residual Ca. 
At this point, the calvarial samples were divided into 4 groups, 
each containing 3 matching calvarial halves. One half of each 
particular calvarium was incubated in 2 ml of a specific concentration 
of con A in supplemented BGJb media while the other half was incubated 
in 2 ml of supplemented BGJb medial without the addition of any con A 
and used as an internal control. The concentrations of con A used in 
this study were 0.1 pg/ml, 2.0 pg/ml, 50 pg/ml and 100 pg/ml. At 24, 
48, and 72 hours, 0.2 ml samples of culture media were pipetted off 
each well and added to 10 ml Biocount liquid scintillation counting 
cocktail (Research Products International, Mount Prospect, 11.). 
Duplicate samples were taken from each well and the remaining media 
was discarded at 24 and 48 hours. Each well was rinsed with HBSS and 
replenished with 2 ml of fresh media. The cultures were terminated at 
12 hours. All samples were counted in a Beckman LS 7000 Liquid 
Scintillation System. 
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RESULTS 
Osteoclasts sequentially treated with concanavalin-A and 
bemocyanin, were labeled with the hemocyanin marker molecule as 
visualized by scanning electron microscopy (SEM). Con A is a 
tetravalent lectin which has a high affinity for ci('-D-glucosyl and 
~-D-mannosyl residues associated with membrane macromolecules, such as 
glycoproteins, glycolipids and polysaccharides. In the labeling 
procedure employed in this study, the cell-bound lectin was visualized 
by hemocyanin, a cylindrical-shaped marker molecule. Hemocyanin is a 
glycoprotein molecule possessing saccharide side chains which can 
interact with free sugar binding sites on the con A molecule, 
indicating the site of con A binding. The dorsal (unapposed) surface 
of all osteoclasts observed by SEM was uniformly labeled (figs. 1 and 
2). The hemocyanin label could be visualized on smooth surfaces, 
microvillous projections and filopodia (figs. 2, 3 and 4). 
Osteoblasts were also labeled with hemocyanin demonstrating con A 
binding sites (figs. 5 and 6). The possiblity of non-specific 
hemocyanin labeling was eliminated by treating calvaria with -<-methyl 
mannoside, a specific sugar inhibitor of con A binding. None of the 
resident bone cells on the endocranial surface of the calvaria treated 
with o<-methyl mannoside and subsequently with hemocyanin were labeled 
with the hemocyanin marker (figs. 7, 8, 9 and 10). These cells were 
indistinguishable from those observed on the calvaria which were 
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conventionally prepared for SEM. Therefore, the hemocyanin label was 
specific for con A binding sites on the outer surface of the cell 
membrane of both osteoclasts and osteoblasts. 
The morphological findings presented indicate that osteoclasts 
have binding sites for con A on their surface. The 45ca bone release 
assays were conducted to determine whether or not con A, at various 
concentrations, had any functional effect on osteoclasts. The ability 
of osteoclasts to resorb bone was determined by the amount of 45ca 
released to the tissue culture media during three 24 hour time periods 
after the release of labile 45ca. Values for the level of 
radioactivity (cpm) were obtained by counting duplicate samples from 
each well at each time period. The mean value (cpm) for each 
calvarial half incubated in a specified concentration of con A was 
divided by the mean value of the corresponding half incubated in 
control media (no con A added) to give a treated/control (T/C) ratio 
for each calvarium. The mean T/C ratio for each of the four 
experimental groups was calculated and compared to the mean 
control/control (C/C) ratio for that same experimental group to 
determine whether the observed changes in bone resorption were 
significantly different. Significance was evaluated by a two-tailed 
Student t-test for the difference between two means. The counts per 
minute of any given duplicate sample never differed by more than 3%. 
In samples incubated in 100 pg/ml con A, the concentration 
utilized for the morphological studies, there was a marked decrease in 
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bone resorption apparent at 24 hours (T/C = 0.76 + 0.05). This trend 
continued at 48 hours and 72 hours (Table l). In all cases the 
differences were significant. At 50 µg/ml con A, there was also a 
significant reduction in bone resorption, although it was not as 
pronounced as it was at 100 pg/ml. The decrease in resorption seen at 
24 hours (T/C • 0.78 + 0.06) continued at 48 hours (T/C = 0.66 :!:. 0.05) 
and 72 hours (T/C • 0.55 :!: 0.05). Presently studies are being 
conducted to determine whether the decrease in resorption at these 
concentrations of con A is due to con A induced inhibition of 
osteoclastic activity, or whether these high concentrations are merely 
cytotoxic to osteoclasts (see Appendix A). 
At mitogenic concentrations of con A (2.0 µg/ml), the 
concentration that results in peak proliferation of rat lymphocytes in 
45 
vitro (Schneider, unpublished), the Ca released from treated 
calvaria did not differ significantly from that of control calvaria at 
24, 48 and 72 hours. However, at a concentration of 0.1 µg/ml con A 
there was an increase in bone resorption. This increase, which was 
seen as a trend at 24 hours (T/C • 1.32 :!: 0.24), became significant at 
48 hours (T/C • 1.44 + 0.21). Although there was a slight decrease in 
the mean T/C ratio at 72 hours (T/C • 1.36 :!: 0.19), the increase in 
resorption remained significant (Table 1). Studies must be conducted 
to determine whether the increase in bone resorption seen at low 
concentrations of con A is the result of a direct or an indirect 
stimulatory effect of con A on the osteoclast. 
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DISCUSSION 
Numerous investigators have recently probed the osteoclast 
membrane attempting to demonstrate receptor sites for various hormones 
and biologically active molecules which regulate osteoclastic 
activity. In an in vitro study utilizing 125I-calcitonin, 
localization of calcitonin receptors on the osteoclast membrane has 
been demonstrated (Warshawsky, et al., 1980). Calcitonin receptors 
have also been demonstrated on osteoclasts by immunohistochemical 
staining (Rao et al., 1981). However, light microscope 
autoradiographs of chick embryo calvaria after exposure to 
125I-parathyroid hormone (PTH; 1-34), another primary hormone 
affecting bone resorption, have revealed PTH receptors on osteoblasts, 
but not osteoclasts (Silve et al., 1982). The lack of PTH receptors 
• 
on osteoclasts is also supported by the recent findings of Chambers 
and Dunn (1982); the addition of PTH to cultures of isolated 
osteoclasts caused no change in their behavior or morphology. 
The hypothesis is that mononuclear phagocytes are the precursors 
of osteoclasts has created an intense investigation to determine if 
these two distinct cell types share a common lineage. Several studies 
have focused on membrane characteristics to determine whether or not 
certain receptor sites known to exist on macrophages, can also be 
demonstrated on osteoclasts. The findings of one study which 
supported this hypothesis, indicated that elicited peritoneal 
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mononuclear phagocytes possess functional receptors for both PTH and 
CT (Minkin et al., 1977). Although Fe and C3 receptors are present on 
macrophages, no one has been able to demonstrate these receptors on 
osteoclasts either in situ (Shapiro et al., 1979; Hogg et al., 1980) 
or in vitro (Chambers, 1979). 
Lectins, proteins that selectively bind carbohydrates but do not 
have enzymatic activity, were initially used to study the surface 
structure and function of lymphocytes. The addition of certain 
lectins to cultured lymphocytes results in changes in their surface 
morphology and function, e.g. lectins have mitogenic activity. 
Recently, lectins have also been used to study the cell membrane 
structure and function of a variety of other specific cell types, 
including phagocytic cells. Haimovitz et al. (1982) demonstrated that 
the in vitro maturation of monocytes to macrophages was accompanied by 
a decrease in the ability to bind fluorescein-labeled peanut 
agglutinin. Horton et al. (1982) demonstrated a dose-dependent 
45 decrease in resorption of Ca pre-labeled long bones incubated in 
high concentrations of con A (50 µg/ml and 100 pg/ml). Subsequently 
TEM studies of osteoclasts incubated in 50 µg/ml con A, revealed 
specific ultrastructural changes associated with inhibition of 
osteoclastic activity (Ryder et al., 1982). These results suggested 
the possibility of specific con A binding sites on osteoclasts. 
Barnicot (1947) reported the peripheral distribution of 
osteoclasts on the inner surface of the flat bones of the skull of 
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io-day old mice. This endocranial surface of calvaria represented an 
easily accessible sit~ to study membrane receptors on osteoclasts. 
SEM has been successfully used to identify resident bone cells on the 
endocranial surface of isolated calvaria (Jones and Boyde, 1976; Jones 
and Boyde, 1977). Therefore, in this study calvaria were scanned for 
osteoclasts immediately adjacent to the sagittal and frontoparietal 
sutures. Fields of osteoblasts occupied centrally located regions of 
the flat skull bones. The existence of con A binding sites on 
osteoclasts and osteoblasts was revealed using the methods described 
by Schneider et al (1979) and Brown and Revel (1976). 
45 The Ca bone release assays were conducted to evaluate the 
effects of various concentrations of con A on the bone resorbing 
capacity of osteoclasts. 45 The increased release of Ca from the 
calvarial halves incubated in 0.1 pg/ml con A at each of the three 24 
hour time periods, may be the result of a direct con A-mediated 
stimulation of osteoclastic activity, or it may be mediated 
indirectly, following interaction of con A with another cell type. 
Con A, by virtue of its binding to specific sugar residues, may 
directly alter the functional state of the osteoclast resulting in 
increased bone resorption at low concentrations. Alternatively, con A 
may act indirectly through an intermediary cell. The mechanism by 
which lectins stimulate lymphocyte production of osteoclast activating 
factor (OAF) has been well documented (Horton et al., 1972; Horton et 
al., 1974). The release of OAF by lymphocytes stimulates osteoclastic 
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activity resulting in an increased resorption of bone. 
The activity of osteoclasts incubated in a mitogenic 
concentration of con A did not significantly differ from that of 
osteoclasts incubated in control media. This result argues against 
the possible role that OAF may play in the indirect stimulation of 
bone resorption. The significant reduction in bone resorption 
observed at 50 and 100 µg/ml con A, is probably the result of a 
dose-dependent con A-mediated inhibition of osteoclastic activity as 
indicated by the TEM studies of osteoclasts incubated in 50 µg/ml for 
48 hours (Ryder et al., 1982). Presently, experiments are in progress 
to verify the reversal of this inhibition of osteoclasts by removing 
con A from the culture media after 24 hours of incubation (see 
Appendix A). 
Chambers and Dunn (1982) and Chambers and Magnus (1982) have 
described various inhibitory morphological changes observed in 
cultured osteoclasts treated with calcitonin and prostacyclin as 
visualized by phase contrast microscopy. Similarly, morphological 
characteristics of presumably active and inhibited osteoclasts, as 
visualized by SEM, have been described, both in situ (Jones and Boyde, 
1977) and in vitro (Allen et al., 1981). If indeed the decrease in 
the bone resorbing activity of osteoclasts observed at high 
concentrations of con A is due to con A-mediated inhibition, and the 
stimulation of osteoclasts at low concentrations is a direct effect of 
con A, this culture system will be useful in describing specific 
44 
morphological characteristics of osteoclasts by SEM. 
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Fig. 1. Osteoclast treated with con A and hemocyanin 
demonstrating a rough surface, the result of 
hemocyanin uniformly distributed over the dorsal 
(unapposed) surface. Bar equals 5.0 um. 
Fig. 2. High magnification of an osteoclast treated with 
con A-hemocyanin. The hemocyanin molecules appear 
as small elevations, giving the microvilli and flat 
.) areas of the cell surface a highly irregular outline. 
Bar equals 0.5 um. 
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Fig. 3. High magnification of labeled osteoclast illustrating 
densely packed hemocyanin molecules on the flat areas 
of the plasme membrane. Bar equals 0.5 um. 
Fig. 4. Hicrovilli at the lateral border of a labeled 
osteoclast shows numerous marker molecules. Bar 
equals 0.5 um . 
. ) 
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Fig. 5. Field of osteoblasts from a sample treated with con A 
and hemocyanin. The rough surface is due to hemocyanin 
molecules. Bar equals 5.0 um. 
Fig. 6. High magnification of a labeled osteoclast, as in figure 
5. Note the presence of uniformly distributed 
hemocyanin molecules. Bar equals 0.25 um. 
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Fig. 7. Control osteoclast treated with con A, ~-methyl 
mannoside, and hemocyanin. No label is present on the 
cell surface. Bar equals 5.0 um. 
Fig. 8. High magnification of a control osteoclast, as in figure 
7. The smooth outline of microvillous projections is 
apparent. Bar equals 0.5 um. 
' 
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Fig. 9. A field of osteoblasts from a control sample, treated 
with con A, ..C:-methyl mannoside, and hemocyanin. Bar 
equals 5.0 um. 
Fig. 10. High magnification of the surface of a control 
osteoblast. Bar equals 0.25 um. 
' 
56 
Table 1 
Concentration of 
con A 
0.1 µg/ml 
2.0 µg/ml 
50 µg/ml 
100 µg/ml 
45ca Bone Release Assay 
24 hour 
T/C Ratioa pb 
48 hour 
T/C Ratio p 
1.32 ± .24 <O. 1 1.44 ± .21 <.05 
1. 07 ± • 12 N • S. 1.05 ± .10 N.S. 
0.78 ± .06 <.01 0.66 ± .05 <.005 
0.76 ± .05 <.005 0.55 ± .01 < .001 
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72 hour 
T/C Ratio p 
1.36 ± .19 <.05 
1.03 ± .11 N.S. 
0.55 ± .05 <.002 
0.42 ± .04 <.001 
a T/C ratio: Mean treated to control ratio of three pairs of corresponding 
calvar1al halves and the standard deviation. 
b p • probability that the mean T/C ratio was the same as the mean CIC ratio 
as detennined by a two-tailed student t-test. 
c N.S. = not significant 
CHAPTER IV 
LECTIN-MEDIATED EFFECTS ON BONE 
RESORPTION IN VITRO 
58 
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ABSTRACT 
Lectins are proteins that are highly specific in their saccharide 
binding requirements. Although lectins have been used extensively as 
in vitro biological probes to study the structure and function of 
--
cells and tissues, few studies have used lectins to evaluate the 
skeletal system. Organ cultures of 45ca pre-labeled bone have been 
used as in vitro models to assess the functional effects of various 
exogenous and endogenous mediators of osteoclastic bone resorbing 
activity. In a previous study, we demonstrated that concanavalin A 
(con A) has a dose-dependent biphasic effect on the bone resorbing 
45 
capacity of osteoclasts using a Ca bone-organ culture system; bone 
resorption was stimulated at low concentrations and inhibited at high 
concentrations. In this study we compared the effects of the 
following 4 lectins, con A, wheat germ agglutinin {WGA), soybean 
agglutinin {SBA) and peanut agglutinin {PNA), each with distinctly 
different saccharide binding specificities, on bone resorption. Organ 
45 
cultures of Ca pre-labeled calvariae were established to quantitate 
bone resorption and each lectin was tested at a concentration of SO 
pg/ml. Both con A and WGA inhibit bone resorption, although the 
VGA-mediated effect is not as pronounced as that of con A. In 
contrast, neither SBA nor PNA have any effect on bone resorption in 
comparison to the control assay. These observations indicate that 
con A- and WGA-mediated inhibition of bone resorption is not a 
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generalized phenomenon that occurs subsequent to the binding of any 
lectin at the same concentration, suggesting that the specificity of 
lectin binding to cell surface receptors is an important factor in the 
regulation of cellular function. Furthermore, lectins such as con A 
and WGA can be used as in vitro models to study the morphological and 
biochemical events associated with changes in osteoclastic activity. 
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INTRODUCTION 
Lectins are proteins that exhibit a variety of biological 
effects, some of which mimic the effects of endogenous, physiological 
agents that regulate cellular function in vivo. Therefore, lectins 
have been used as in vitro models to study the biochemical events and 
morphological changes associated with alterations of cellular 
activity. Lectins offer a number of attractive features as biological 
probes. They are highly specific in their cell surface saccharide 
binding requirements. Hapten inhibition studies have demonstrated 
that the interactions between lectins and cell surface saccharides can 
be inhibited by the addition of simple sugars. Most of the lectins 
that have been isolated and analyzed to date are composed of multiple 
subunits which are held together by non-covalent bonds. These 
subunits are polypeptide chains that frequently contain covalently 
bound carbohydrate side chains. There are a multitude of lectins that 
are commercially available in high purity and they can be conjugated 
to a variety of ultrastructural and cytochemical marker molecules. 
Concanavalin A (con A) is the most widely used lectin in 
biological assays and many of its properties have been well-documented 
and thoroughly investigated. Other lectins that are frequently used 
to study the structure and function of cells and tissues include wheat 
germ agglutinin (WGA), soybean agglutinin (SBA) and peanut agglutinin 
(PNA). The sugar specificities of con A, WGA, SBA and PNA are 
62 
distinctly different from one another (Table 1). All of the sugar 
residues to which these lectins bind are common to mammalian 
membrane-associated glycoconjugates. 
The biological effects of these 4 lectins have been investigated 
in a variety of cellular systems both in vivo and in vitro. However, 
few studies have used lectins to evaluate the structure and function 
of the skeletal system. Wang et al. (1982) demonstrated that the in 
vivo administration of PHA-P caused a significant increase in the 
number and size of long bone osteoclasts. Horton et al. (1982) 
demonstrated a decrease in resorption of long bones cultured in the 
presence of high concentrations of con A (50 and 100 µg/ml). 
Subsequent transmission electron microscopy of these con A-treated 
osteoclasts revealed ultrastructural changes associated with 
inhibition of osteoclastic activity (Ryder et al., 1982). 
The studies involving the skeletal system indicate that some 
lectins can induce changes in the structure and function of bone 
cells, particularly osteoclasts. The osteoclast is a large 
multinucleate cell that is widely accepted as the primary effector 
cell responsible for normal bone resorption (Marks, 1983). In a 
45 previous study, we conducted a series of in vitro Ca bone release 
assays to evaluate the effect of various concentrations of con A on 
the bone resorbing capacity of osteoclasts (Popoff and Schneider, 
1983). The bone mineral release assays demonstrated that con A has a 
biphasic effect; at a low concentration (0.1 µg/ml) con A increased 
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bone resorption, whereas at higher concentrations (50 and lOOpg/ml) 
con A inhibited bone resorption. In this study we were interested in 
comparing the effects of the lectins con A, WGA, SBA and PNA, each 
with different saccharide binding specificities, on bone resorption. 
45 We used a bone-organ culture of Ca pre-labeled calvariae to 
quantitate bone resorption and tested each lectin at a concentration 
of 50 µg/ml. 
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MATERIALS AND METHODS 
The procedure employed in these bone mineral release assays is 
similar to that described in a previous study (Popoff and Schneider, 
1983). The calvariae of 7-day old Norway Hooded rats were pre-labeled 
45 by injecting the animals with 40 µCi of Ca per rat (specific 
activity 10-40 mCi/mg calcium, Amersham, Arlington Heights, 11.). 
Three days later, the animals were anesthetized with ether and 
sacrificed. The calvariae were removed under sterile conditions and 
placed into Hanks' Balanced Salt Solution (HBSS). The dura mater and 
periosteum were dissected off the endocranial surface and the 
calvariae were rinsed in HBSS. Each calvaria was split longitudinally 
down the sagittal suture, and corresponding halves were placed into 
adjacent wells of a 24-well Costar tissue culture cluster. Each well 
contained 2 ml of BGJb medium supplemented with 5% Fetal Bovine Serum, 
100 units/ml Penicillin-Streptomycin and 0.292 mg/ml Glutamine. The 
calvarial halves were incubated at 37°C for 24 hours in 5% co2 and air 
to remove the labile 45ca. After 24 hours, the medium was discarded 
and the wells were rinsed with HBSS to remove any residual 45ca. 
At this point, the calvarial samples were divided into 5 groups 
with each group containing 6 matching calvarial halves. The 5 groups 
correspond to the 4 lectins, con A, WGA, SBA, and PNA, to be tested 
and one group for the control release assay. In the experimental 
cultures, one half of each particular calvaria was incubated in 2 ml 
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of supplemented BGJb medium containing one of the four lectins at a 
concentration of 50 µg/ml, while the other half was incubated in 2 ml 
of supplemented BGJb medium without the addition of any lectin and 
used as an internal control. In the control cultures both halves of 
each pair were incubated in supplem:nted BGJb medium in the absence of 
lectin. At 24, 48 and 72 hours, 0.2 ml samples of culture medium were 
pipetted off each well and added to 10 ml Biocount liquid 
scintillation counting cocktail (Research Products International, 
Mount Prospect, Il.). Duplicate samples were taken from each well and 
the remaining medium was discarded at 24 and 48 hours. Each well was 
rinsed with HBSS and replenished with 2 ml of fresh medium. The 
cultures were terminated at 72 hours and the remaining bone samples 
were placed into scintillation vials and digested in 0.5 ml formic 
acid at l00°c for 30 minutes. Following the bone digest, 10 ml 
counting cocktail was added to each vial. All samples were counted in 
a Beckman LS 7000 Liquid Scintillation System. The bone digest was 
45 performed so that the percent of Ca released from each calvarial 
45 
sample with respect to the total Ca initially present in that sample 
could be calculated. 
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RESULTS 
45 The Ca bone release assays were conducted to evaluate the 
effects of the lectins, con A, WGA, SBA and PNA, on bone resorption. 
Bone resorption was quantitated by the amount of 45ca released into 
the tissue culture medium during three 24 hour time periods after the 
45 
release of labile Ca. Values for the level of radioactivity (cpm) 
were obtained by counting duplicate samples from each well at each 
time period. The counts per minute obtained from duplicate samples 
never differed by more than 3%. The percent 45 ca released from each 
calvarial sample (% release) at each sampling time point was 
calculated from the cpm values after the bone digest was performed. 
The value (% release) for each calvarial half incubated in the 
presence of a specific lectin was divided by the value (% release) of 
the corresponding half incubated in control medium (no lectin added) 
to give a treated/control (T/C) ratio for each calvaria. The mean T/C 
ratio for each of the four experimental groups was calculated and 
compared to the mean control/control (C/C) ratio obtained from the 
control assay to determine whether the observed changes in bone 
resorption were significantly different. Significance was evaluated 
by a two-tailed Student t-test for the difference between two means. 
The mean C/C ratios obtained from paired calvarial halves 
incubated in the absence of lectin varied slightly from the expected 
Value of 1.00 (24 hr. T/C = 1.02 ± 0.02; 48 hr. T/C = 1.04 ± 0.02; 72 
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hr· T/C = 1.02 .± 0.03). The calvarial samples incubated in the 
presence of con A showed a significant decrease in bone resorption at 
24 (T/C = 0.78 + 0.06), 48 (T/C = 0.66 + 0.05), and 72 (T/C = 0.55 + 
- -
o.06) hours (Fig. 1). In a previous study (Popoff and Schneider, 
1983), we have shown that the reduction in mineral mobilization 
mediated by con A at a concentration of 50 µg/ml is reversible, 
indicating that this concentration is inhibitory rather than cytotoxic 
to the bone resorbing osteoclasts. In the samples incubated in 
50 µg/ml WGA, there was a slight decrease in bone resorption at 24 
hours (T/C • 0.95 ::!: 0.03), which became significant at 48 (T/C • 0.84 
+ 0.04) and 72 (T/C • 0.71 .± 0.05) hours (Fig. 1). The decrease 
observed in the WGA-treated samples was not as pronounced as that 
observed in the con A-treated samples at each of the sampling time 
points. 45 On the contrary, the Ca released from the calvarial halves 
incubated in the presence of either SBA or PNA did not differ 
significantly from that of control halves at any sampling time point 
(Fig. 1). The T/C ratios obtained from the SBA-treated assay were 
1.00 + 0.04 at 24 hours, 0.98 ± 0.05 at 48 hours and 0.98 + 0.05 at 72 
hours. The T/C ratios obtained from the PNA-treated samples were 1.01 
± 0.08 at 24 hours, 0.97 + 0.01 at 48 hours and 0.94 + 0.06 at 72 
hours. 
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DISCUSSION 
The lectins con A, WGA, SBA and PNA are highly specific in their 
cell surface saccharide binding requirements and the 
membrane-associated saccharides to which they bind are distinctly 
different from one another (Table 1). Con A has a broad biological 
applicability primarily because it recognizes 2 commonly occurring 
cell surface saccharides, ~-D-mannose and o(-D-glucose. Although it 
was originally postulated that the specificity of con A is directed 
toward a single sugar residue, studies by So et al. (1968) 
demonstrated that the con A binding site is more complex in both its 
primary structure and three-dimensional configuration than originally 
proposed. WGA binds to oligosaccharides containing terminal 
N-acetylglucosamine (GluNAc) residues, with preferential binding to 
dimers and trimers of this saccharide. SBA preferentially binds to 
oligosaccharides containing of..- or p-linked N-acetylgalactosamine 
(GalNAc) residues, and to a lesser extent to D-galactose residues. 
PNA binding is directed toward D-galactose residues, although this 
lectin binds to the disaccharide, galactosyl {1-l,3GalNAc (T-antigen), 
with greatest affinity. Con A, WGA, SBA and PNA are multimeric 
lectins; con A and PNA are each composed of 4 identical subunits, 
whereas WGA and SBA are each composed of 2 identical subunits (Table 
1). SBA and PNA are glycoproteins and the sugars which have been 
isolated from these lectins are common to animal cell membranes. In 
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contrast, con A and WGA are devoid of covalently bound carbohydrate 
side chains (Table 1). 
45 In this study, a series of Ca bone release assays were 
conducted using a lectin concentration of 50 pg/ml for each of the 4 
lectins to be tested. The results demonstrate that both con A and WGA 
45 inhibit the release of Ca in cultures of pre-labeled calvarial 
explants, although the WGA-mediated effect is not as pronounced as 
that of con A. On the contrary, neither SBA nor PNA have any effect 
on bone resorption in comparison to the control assay run in the 
absence of any lectin. These findings indicate that the inhibition of 
bone resorption mediated by con A, and to a lesser extent by WGA, at a 
concentration of 50 pg/ml is not a generalized phenomenon that occurs 
subsequent to the binding of any lectin at this concentration. This 
conclusion would suggest that the specificity of lectin binding to 
cell surface receptors is an important factor in the regulation of 
cellular function that is mediated by a particular lectin. Studies 
should be conducted to evaluate possible mechanisms that could be 
responsible for the differential effects of these lectins on bone 
resorption. 
Because of the difficulty in obtaining pure populations of 
osteoclasts, most of the studies on bone resorption are performed on 
intact animals or bone-organ cultures. These systems do not permit 
detailed analysis of the cellular mechanisms of bone resorption 
(Teitelbaum et al., 1979). Studies by Mundy et al. (1977), Kahn et 
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al. (1978) and Teitelbaum et al. (1979) have demonstrated that 
monocytes and macrophages are capable of resorbing devitalized bone in 
vitro. The studies by Kahn et al. (1978) and Teitelbaum et al. (1979) 
------
also demonstrated that optimal macrophage-mediated mineral 
mobilization requires cell-matrix contact. Since macrophages are 
capable of attaching to and subsequently degrading a bone matrix, the 
macrophage-devitalized bone culture system serves as a useful model to 
study the mechanisms of bone resorption in tissue culture (Bar-Shavit 
et al., 1983a). Recent studies by Bar-Shavit et al. (1983b,c) have 
shown that the attachment of macrophages to bone is a regulated 
process that is mediated, in part, by certain saccharides located on 
the cell and/or bone surfaces. These findings indicate that the 
attachment of resorbing macrophages to the bone matrix is an important 
component of the process of bone resorption and that the 
oligosaccharide-mediated binding mechanism that links the resorbing 
macrophages to bone is essential for normal resorptive activity. The 
macrophage-devitalized bone culture system could be used to evaluate 
45 the effects of lectins, that have differential effects on Ca release 
in cultures of pre-labeled calvariae, on the morphological and 
functional aspects of the macrophage-bone interaction. 
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Fig. 1. 45 Ca bone release assay. SBA and PNA had no significant 
effect on bone resorption at a concentration of 50 
pg/ml, whereas con A and WGA inhibited bone resorption 
at this concentration . 
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Table 1 Lect1n Spec1f1c1ty 
Structure 
Saccharide Specificity 
and Cation Chemica 1 # of 
Lectin Source Binding Affinity Requirement Composition Subunits MW (daltons) 
Concanavalin A Canavalia ensifonnis a-0-mannose + protein tetramer 104 ,000 (Con A) (Jack bean) seeds 
a-D-glucose 
---------------------- ----------------------- ------------------------ -------------- -------------- -------------- --------------
Peanut Agglutinin Arachis hypogaea D-galactose + gl ycoprotei n tetramer 110,000 
(PNA) (peanuts) -galactosyl 6-1,3 GalNAc 
---------------------- ----------------------- ------------------------ -------------- --------------
1--------------
---------------
Soybean Agglutinin Glycine max (soybean) D-GalNAc + glycoprotein tetramer 120,000 
(SBA) seeds D-galactose 
---------------------- ----------------------- ------------------------ -------------- --------------
1--------------
---------------
Wheat Germ Agglutinin Triticum vulgaris (D-GluNAc) 3/Z/l protein dimer 36,000 (WGA) (wheat germ) -
CHAPTER V 
THE EFFECTS OF LECTINS ON THE INTERACTION 
BETWEEN MACROPHAGES AND BONE IN VITRO: 
A MORPHOLOGICAL AND FUNCTIONAL STUDY 
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SUMMARY 
Recent studies have demonstrated that the attachment of elicited 
rat macrophages to bone is mediated by specific saccharides located on 
the cell and/or bone surfaces. We have used a macrophage-bone culture 
system to study the effects of 2 lectins, concanavalin A (con A) and 
soybean agglutinin (SBA), on the morphology of macrophage attachment 
to a devitalized bone surface and subsequent functional activity. 
Macrophages were obtained from 3-4 week old rats by peritoneal lavage 
and the adherent pool was used to prepare cell suspensions. Con A-
treated, SBA-treated or control cell suspensions were aliquoted onto 
the endocranial surface of devitalized rat calvariae. The cells were 
allowed to attach for lh at 37°c, after which, the bone samples were 
removed from culture and prepared for scanning electon microscopy 
(SEM). The morphology of con A-treated macrophages attached to bone 
was markedly different from that of control or SBA-treated cells. 
Con A altered the attachment and subsequent spreading of macrophages 
on bone as visualized by SEM. Furthermore, the number of con A-
treated cells that attached to bone and the average surface area of 
cell membrane apposed to the matrix was significantly different from 
that of control or SBA-treated cells. 45 A Ca bone release assay was 
performed to evaluate the functional significance of the morphological 
findings. Lectin-treated or control cell suspensions were allowed to 
attach to the endocranial surface of 45ca pre-labeled calvariae for 
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lh· Following attaclunent, the samples were cultured for 72h. The 
con A-treated cultures demonstrated a significant decrease in the 
45 
release of Ca after 48 and 72h in comparison to control c~ltures, 
45 
while the Ca released from SBA-treated cultures did not differ 
significantly from controls. These results suggest that certain sugar 
residues common to membrane-associated glycoconjugates and the organic 
component of the bone matrix regulate the attachment of macrophages to 
bone and their subsequent bone resorbing activity. 
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INTRODUCTION 
The hypothesis that the osteoclast precursor is extraskeletal in 
origin has been recently accepted (Marks 1983). Although the 
definitive origin of the osteoclast remains uncertain, there is 
abundant evidence to support the hypothesis that osteoclasts are 
derived from mononuclear cells of hemopoietic origin, possibly of the 
monocytic lineage (Walker 1975; Marks and Walker 1981; Schneider and 
Byrnes 1983). In addition to the investigative effort to establish a 
common lineage between the osteoclast and the macrophage mononuclear 
cell, it has been well-documented that cells of the mononuclear 
phagocyte system are capable of resorbing devitalized bone in vitro 
(Mundy et al. 1977; Kahn et al. 1978; Teitelbaum et al. 1979). The 
studies by Kahn et al. (1978) and Teitelbaum et al. (1979) also 
demonstrated that optimal macrophage-mediated mineral mobilization 
requires cell-matrix contact. These findings indicate that the 
attachment of resorbing mononuclear cells to the bone matrix is an 
important component of this process. 
More recently, Bar-Shavit et al. (1983a,b) have shown that the 
attachment of macrophages to bone is a regulated process that is 
mediated, in part, by saccharides located on the cell and/or bone 
surfaces. These investigators have also shown that glucocorticoids 
enhance the attachment of macrophages to bone in a dose-dependent 
manner which parallels the dose-dependent stimulation of 
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macrophage-mediated bone resorption by glucocorticoids (Bar-Shavit et 
al. 1984). The increase in macrophage attachment involves 
glucocorticoid-induced alterations of cell surface oligosaccharides. 
Bar-Shavit et al. (1982, 1983c) also demonstrated that macrophages 
attach to osteomalacic bone with significantly less avidity than 
normal matrix. They attributed this reduction in binding to the 
absence or inaccesibility of the appropriate bone matrix 
oligosaccharides. From these studies it was concluded that the 
oligosaccharide-mediated binding mechanism which links the resorbing 
mononuclear cells to bone is essential for normal resorptive activity. 
Since monocytes and macrophages are capable of attaching to and 
subsequently degrading a mineralized bone matrix, the macrophage-bone 
culture system serves as a useful model to study the interaction 
between macrophage mononuclear cells and bone. Therefore, we used a 
macrophage-bone culture system to study the effects of two lectins, 
concanavalin A (con A) and soybean agglutinin (SBA), on the morphology 
of cell attachment and subsequent functional activity. Lectins are 
proteins that are highly specific in their saccharide binding 
requirements. Lectins have been used extensively in biological 
assays, particularly as probes to study the strucure and activity of 
membrane components. The two lectins employed in this study have 
saccharide binding specificities that are distinctly different from 
one another. Con A binds to oligosacharides witho(.-linked D-glucose 
and D-mannose residues, whereas SBA preferentially binds to 
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oligosaccharides with ol- or ~-linked N-acetylgalactosamine (GalNAc) 
residues, and to a lesser extent to D-galactose residues. For this 
study, scanning electron microscopy (SEM) was used to assess the 
qualitative and quantitative differences in the attachment of 
macrophages to bone in the presence and absence of lectin. 
45 Furthermore, a Ca bone release assay was performed to evaluate the 
functional significance of the morphological findings. 
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MATERIALS AND METHODS 
Mononuclear cells for all experiments were obtained from 3 to 4 
week old Norway Hooded rats by intraperitoneal injection of cold 
0 
saline (4 C), as described by Schneider and Byrnes (1983). The 
abdomen was massaged for a few minutes and the fluid was aspirated 
from the peritoneal cavity. Adherent cells were separated from 
nonadherent cells by incubating the peritoneal washes in RPM! 1640 
medium supplemented with 10% Fetal Bovine Serum in 35 mm plastic 
tissue culture dishes (5 X 106 cells/dish). After 2h, the nonadherent 
pool was decanted and the cultures were rinsed in phosphate buffered 
saline (PBS). The remaining attached cells were incubated in 
calcium-, magnesium-free Hanks' Balanced Salt Solution (HBSS) for 15 
min at 4°C. The cells were removed from the plastic surface by gentle 
scraping using a rubber policeman. The resulting cell suspensions 
were counted on a hemocytometer. Approximately 95% of the adherent 
cells were macrophages, as assessed by their ability to phagocytose 
the particulate dye, neutral red. 
Morphology and quantitation of macrophage attachment to bone in the 
Rresence of con A and SBA 
The cell surface morphology of macrophages attached to bone in 
the presence of con A and SBA was visualized by scanning electron 
microscopy (SEM). Three cell suspensions containing equivalent 
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numbers of macrophages were prepared for this experiment: 1) a con A 
treated cell suspension in BGJb medium containing 50 pg/ml con A 
(Pharmacia, Piscataway, N.J.); 2) an SBA treated cell suspension in 
BGJb medium containing 50 pg/ml SBA (Pharmacia, Piscataway, N.J.); 3) 
and a control suspension of cells in BGJb medium without the addition 
of lectin. The BGJb medium used in all tissue culture procedures was 
supplemented with 10% Fetal Bovine Serum, 100 units/ml 
Penicillin-Streptomycin and 0.3mg/ml Glutamine. The lectin 
concentration of 50 pg/ml was selected based upon previous results 
which demonstrated that con A significantly inhibits the release of 
45ca from a bone organ culture system at this concentration, whereas 
45 the release of Ca from SBA-treated cultures is not significantly 
different from controls (Popoff et al. 1984). 
Devitalized bone chips were prepared from the calvariae of 10 day 
old Norway Hooded rats by freeze-thawing and sonication. Three 
devitalized bone chips were placed onto the bottom of each of 6 tissue 
culture wells, the wells being divided into 3 groups corresponding to 
the three cell suspensions. The cell suspensions were then layered 
over the bone chips and the cells were allowed to attach for lb. 
Bar-Shavit et al. (1983) have shown that elicited rat peritoneal 
macrophages bind to bone in a temperature-dependent and saturable 
0 
manner with maximal attachment occurring at 60 min at 37 C. Following 
attachment the bone chips were removed from culture and rinsed in PBS. 
After the bone attachment assay, all bone samples were fixed in 
83 
2.5% glutaraldehyde in 0.1 M cacodylate buffer for lh. Following 
fixation, the samples were rinsed in cacodylate, dehyrated through a 
graded series of ethanol, critical point dried via co2 using a Denton 
DCP-1 (Denton Vacuum, Cherry Hill, N.J.), attached to aluminum stubs 
and coated (20 nm thickness) with Gold/Palladium using a Hummer VI 
sputter-coating apparatus (Technics, Alexandria, Va.). The specimens 
were scanned using an ISI SX40 (Santa Clara, Ca.) at an accelerating 
0 0 
voltage of 15kV and either a 0 or 45 tilt. These samples were used 
to evaluate cell surface morphology and to quantitate the attachment 
of macrophages to bone. 
To quantitate the number of macrophages attached to the bone 
surface, 5 different fields of each bone sample were selected using 
identical x:y coordinates for each sample. These fields were 
photographed at 300X, a magnification that allows for the accurate 
~ 
identification of individual cells. The cells were then counted on a 
Zeiss Videoplan Image Analyzer (Carl Zeiss, New York, N.Y.). To 
51 
validate this method of quantitation by SEM, a Cr bone binding assay 
similar to that described by Bar-Shavit et al. (1983d) was employed. 
Macrophages were radiolabeled by incubation for lh at 37°c in a 
51 
solution containing Na Cr04 in RPMI 1640 medium at a concentration of 
50 pCi/10 X 106 cells. After washing the radiolabeled cells in PBS, 
they were resuspended in the following media; control cells in 
supplemented BGJb medium and treated cells in supplemented BGJb medium 
containing 50 pg/ml of con A. The control and treated cell 
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suspensions, each containing an equivalent number of radiolabeled 
macrophages, were aliquoted onto the endocranial surface of 6 
devitalized calvarial chips and the cells were allowed to attach for 
0 lh at 37 C. All calvarial chips used in this experiment were 
identical in size. After rinsing, the bone chips, with their attached 
radiolabeled cells, were counted in a Beckman Gamma 4000 system. A 
pre-determined number of radiolabeled cells were also counted, 
allowing for an approximate determination of the number of attached 
macrophages from the counts per minute (cpm) obtained from the gamma 
counter for each bone chip. 
To quantitate the average cell surface area apposed to the bone 
surface in the presence or absence of either con A or SBA, fields of 
attached macrophages were photographed at lOOOX. From these 
micrographs, the perimeter of individual cells on the bone surface 
could accurately be traced using a Zeiss Videoplan Image Analyzer 
(Carl Zeiss, New York, N.Y.). 100 cells in each group were traced on 
the image analyzer, which was calibrated to convert this measurement 
2 parameter into the corresponding surface area in pm • The individual 
surface area measurements in each group were averaged and significance 
was evaluated by a two-tailed student t-test. 
Macrophage mediated release of bone mineral 
The calvariae of twelve 7-day old Norway Hooded rats were 
45 pre-labeled by injecting the animals with 40 pCi of Ca per rat. 
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Three days later, the calvariae were removed and the dura mater was 
dissected off the endocranial surface. After being devitalized, each 
calvaria was split longitudinally down the sagittal suture and 
corresponding halves were placed into adjacent tissue culture wells. 
The culture plates were placed under an ultraviolet light source for 
12h to assure that all calvariae were sterile. Following 
sterilization, 2 ml of PBS was added to each well for 24h to remove 
45 the labile Ca. 
After the washout period, lectin-treated and control macrophage 
cell suspensions were prepared in supplemented BGJb medium as 
previously described. The calvarial samples were divided into 2 
groups (con A and SBA), each containing 6 matching calvarial pairs. 
Two ml of either the con A-treated or SBA-treated cell suspension was 
aliquoted into the wells containing one half of each calvarial pair, 
while 2 ml of the control cell suspension was aliquoted into the wells 
containing the corresponding half of each calvarial pair. An 
equivalent number of cells (treated or control) was aliquoted into 
each well. At 24, 48 and 72h, duplicate 0.2 ml samples of culture 
medium were pipetted off each well and added to 10 ml Ready-Solv 
liquid scintillation counting cocktail (Beckman, Fullerton, Ca.). The 
remaining medium was discarded at 24 and 48 hours and replenished with 
2 ml of fresh medium. Cell viability in control, con A-treated and 
SBA-treated cultures after 72h was determined by the trypan blue dye 
exclusion method. 
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After terminating the cultures at 72h, the calvarial samples were 
rinsed in PBS, placed into scintillation vials, and digested in 0.5 ml 
formic acid at l00°C for 30 min. Following calvarial digest, 10 ml 
counting cocktail was added to the vials. All samples were counted in 
8 Beckman LS 7000 Liquid Scintillation System. The calvarial digest 
45 
was performed so that the percent of Ca released from each calvaria 
45 
with respect to the total Ca initially present in that calvaria 
could be calculated. 
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RESULTS 
!_orphology of macrophage attachment to bone 
0 Macrophages that are allowed to attach to a bone surface at 37 C 
in the absence of lectin, will interact with the bone surface and 
spread beyond the original site of attachment. After lh in culture, 
the macrophages are in various stages of the spreading process; some 
cells exhibit a proportionately large membrane surface area that is 
apposed to the bone surface, while others are in a more immature phase 
of the spreading process (fig. 1). Many filopodia as well as some 
larger lamellipodia are present at the cell periphery (fig. 2). The 
dorsal, unapposed surface exhibits numerous microspikes (fig. 2). 
Macrophages that are allowed to attach to bone in the presence of con 
A exhibit a cell surface morphology that is markedly different from 
that of controls (fig. 3). Although the con A-treated macrophages do 
attach to the bone surface, they are hindered in their ability to 
spread on the substrate. A much smaller proportion of the total 
membrane surface area of con A-treated macrophages is apposed to the 
bone matrix in comparison with controls. Membrane specializations at 
the cell periphery are present in the form of a few blunt 
lamellipodia, while filopodia are absent; the dorsal surface is 
ruffled (fig. 4). In addition, some of the macrophages are present in 
aggregates, most likely the result of the cross-linking of cell 
membranes by con A. Macrophages attaching to bone in the presence of 
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SBA exhibit an extensive membrane-substrate interaction similar to 
controls. Many of the SBA-treated macrophages have a large membrane 
surface area that is apposed to the bone matrix, while others are less 
advanced in the spreading process (fig. 5). The surface morphology of 
SBA-treated macrophages includes large peripheral pseudopodia and a 
ruffled dorsal surface (fig. 6). Macrophage agglutination by SBA is 
not nearly as pronounced as with con A; most of the cells are present 
either singly or in small clusters. 
guantitation of macrophage attachment to bone 
The number of macrophages attaching to bone in the presence or 
absence of either con A or SBA was quantitated via SEM as described in 
Methods. Significance was evaluated by a two-tailed Student t-test 
for the difference between two means. The number of macrophages 
attaching in the con A system is significantly greater than the number 
of cells attaching in the absence of lectin (fig. 7). On the 
contrary, the number of attached SBA-treated cells is not 
significantly different from that of controls (fig. 7). A 
51 Cr-labeled macrophage-bone binding assay was performed to confirm 
the significant increase in the number of con A-treated macrophages 
attaching to bone. The mean level of radioactivity (cpm) obtained 
from control samples was 18,025 + 3097, while the mean cpm for 
con A-treated samples was 34,285 + 6118 (p < .005). The level of 
51 
radioactivity for a fixed number of Cr-labeled macrophages was also 
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6 
obtained (l.6 X 10 cells= 267,118 cpm). From this data, the 
2 
relative cpm values were converted to the number of cells per 32 mm , 
the surface area of each bone sample (control 108,151 .± 18,614; con A 
205,709 .± 36,603). 
The surface area of cell-matrix contact in the presence or 
absence of either con A or SBA was quantitated per cell by tracing the 
perimeter of attached cells on a Zeiss Videoplan Image Analyzer. The 
average cell surface area of con A-treated macrophages apposed to the 
bone surface is significantly less than the average cell surface area 
2 2 
of control macrophages (con A 24.8 .± 6.5 pm ; control 55.6 .± 17.4 pm ; 
p<.001). On the contrary, the average membrane surface area apposed 
to bone in the SBA-treated system is not significantly different from 
2 that of controls (SBA 58.4 ~ 20.l µm ). 
Macrophage mediated release of bone mineral 
The morphological findings confirm the hypothesis that specific 
saccharides common to cell surface and/or matrix associated 
glycoconjugates are involved in the interaction between macrophages 
and bone. Therefore, lectins specific for these saccharides can both 
qualitatively and quantitatively modify the macrophage-bone 
interaction. 45 A Ca bone release assay was performed to determine 
whether the observations made by SEM could be correlated to any 
functional differences in the ability of lectin-treated macrophages to 
' 
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release Ca in vitro. 
The ability of macrophages to degrade a mineralized bone matrix 
was determined by the amount of 45ca released into the culture medium 
45 during three 24h periods after the release of labile Ca. Values for 
the level of radioactivity (cpm) were obtained by counting duplicate 
samples from each well at each time period. The mean value (cpm) for 
each calvarial half incubated in either con A or SBA was divided by 
the mean value of the corresponding half incubated in control medium 
to give a treated/control (T/C) ratio for each calvaria. The mean T/C 
ratio for the two experimental groups was calculated. These values 
were compared to the mean control/control (C/C) ratio to determine 
whether the observed changes in bone resorption were significantly 
different. The C/C ratios were obtained from an assay in which both 
calvarial halves of each pair were incubated in the absence of either 
lectin. Significance was evaluated by a two-tailed Student t-test for 
the difference between two means. 
In the macrophage-bone samples incubated in 50 pg/ml con A, the 
same concentration that was utilized for the morphological studies, 
there was a marked decrease in the release of 45ca from bone at 48h 
(T/C • 0.83 + .07; p < .005) and 72h (T/C • 0.72 .± .09; p < .002) 
(fig. 8). 45 On the other hand, the Ca released from the 
macrophage-bone samples incubated in 50 pg/ml SBA did not differ 
significantly from that of controls at 24, 48 and 72h (fig. 8). In 
addition, the actual C/C values never differed by more than 5% from 
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the ideal value of 1.0 at any of the three sampling time points. The 
viability of macrophages incubated in con A, SBA and control medium 
-as also determined after 72h using the trypan blue dye exclusion 
•ethod. Cell viability ranged between 757. to 807. in all wells tested. 
This excludes the possibility that the reduction in the release of 
45ca from con A-treated samples may have been the result of a 
selective increase in cell death at 48 and 72h. 
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DISCUSSION 
The hypothesis that mononuclear phagocytes are the precursors of 
osteoclasts has created an intense investigation to determine if these 
two distinct cell types share a common lineage and function. Most 
studies have focused on ultrastructural and functional similarities 
between cells belonging to the family of mononuclear phagocytes and 
osteoclasts on a bone matrix. It has been well-documented that cells 
of the mononuclear phagocyte system resorb devitalized bone in vitro 
(Mundy et al. 1977; Kahn et al. 1978; Teitelbaum et al. 1979). 
Glowacki et al. (1981) recently developed a model system in which they 
implanted devitalized bone fragments into calvarial defects in rats, 
thereby initiating a rapid cell-mediated resorptive sequence. A 
histological and ultrastructural study of these implants by Holtrop et 
al. (1982) demonstrated that the cells surrounding the bone fragments 
belong to the mononuclear phagocyte system. However, none of these 
cells, even the multinucleate giant cells, had ruffled borders, a 
morphological hallmark of osteoclasts, and therefore, could not be 
classified as osteoclasts. Other studies have also demonstrated that 
macrophages attached to bone acquire a number of the morphological 
characteristics of osteoclasts in culture, with the exception of 
ruffled borders (Kahn et al. 1978; Rifkin et al. 1979). All of these 
studies indicate that cells of the mononuclear phagocyte system are 
capable of resorbing bone both in~ and in vitro. 
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Hore recently, Bar-Shavit et al. (1983a,b) have used a 
macrophage-bone binding assay to show that the attachment of 
macrophages to bone can be inhibited by certain sugars, while others 
have little or no effect. In a separate study, they have demonstrated 
that the glucocorticoids, dexamethasone and cortisol, enhance the 
attachment of macrophages to bone in a dose-dependent manner by 
causing alterations of cell surface oligosaccharides (Bar-Shavit et 
al. 1984). On the other hand, these investigators have shown that 
macrophage-bone attachment is greatly reduced in both vitamin D 
deficiency and hypophosphatemia (Bar-Shavit et al. 1982; Bar-Shavit et 
al. 1983c). They attribute this reduction in binding to the absence 
or inaccessibility of the bone matrix and/or cell surface 
oligosaccharides that are essential to the attachment process. These 
studies suggest that the reduction in bone resorption accompanying 
certain disease states or the stimulation of resorption induced by 
glucocorticoid treatment may, at least in part, depend on the ability 
of osteoclasts and their precursors to properly attach to the bone 
matrix, a step that appears to be essential for normal resorptive 
activity and osteoclast differentiation. 
Lectins, proteins that selectively bind carbohydrates but do not 
have enzymatic activity, were initially used to study the surface 
structure and function of lymphocytes. More recently, the biological 
effects of different lectins on a variety of cellular systems have 
been investigated both in vivo and in vitro. Based on hapten 
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inhibition studies, which demonstrate that lectin-ligand binding can 
be inhibited by simple ~ugars, most lectins are highly specific in 
their cell surface saccharide binding requirements. In this study we 
used 2 lectins, each having distinctly different saccharide binding 
specificities, to study the importance of specific oligosaccharides on 
the attachment of macrophages to bone, and the subsequent release of 
45ca from the matrix. Con A binds to o<-linked D-glucose and D-mannose 
residues, whereas SBA preferentially binds to-<- or /3-linked GalNAc 
residues, and, with lesser avidity, to D-galactose residues. 
Therefore, cell surface and matrix associated oligosaccharides 
containing these particular sugars will bind the appropriate lectin, 
and, as a consequence, the lectin bound oligosaccharides will be 
unable to directly participate in the macrophage-bone interaction. 
The morphological findings indicate that con A does hinder the 
ability of macrophages to interact with the bone matrix. The membrane 
surface area that is apposed to the bone surface in the con A-treated 
system is far less than that of control macrophages; the con A-treated 
cells exhibit a minimal degree of attachment to the substrate. On the 
contrary, SBA does not appear to change the attachment and subsequent 
spreading of macrophages on bone. However, the dorsal, unapposed 
surface of both con A- and SBA-treated macrophages is ruffled; the 
microspikes present on control cells are absent. In addition, the 
morphology of the cell periphery is also different in lectin-treated 
cells. These differences in cell surface morphology may be due to the 
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processing of membrane-bound lectin complexes. Many of the biological 
effects of lectins are subsequent to binding, which in turn, alters 
the structure and activity of membrane components. Con A has been 
used extensively to study the redistribution and endocytosis of 
lectin-binding site complexes in a variety of cell types. An 
ultrastructural study by Welsch and Schumacher (1983) demonstrated 
that rat pulmonary macrophages bound and incorporated large amounts of 
con A in vivo. Additional studies should be conducted, to assess the 
manner in which membrane-bound con A and SBA are processed by these 
resident peritoneal macrophages in vitro, including the possible 
redistribution and/or endocytosis of these complexes. 
The quantitative data demonstrates that approximately twice the 
number of con A-treated macrophages attached to the bone surface in 
comparison with the number of untreated cells. Although these results 
45 
seem to conflict with the Ca release data, this quantitative 
difference is most likely the result of the extensive aggregation of 
macrophages by con A. The cross-linking of cell membranes by con A 
may significantly increase the number of cells that appear to attach 
to the bone matrix, since those cells that would not attach under 
normal conditions appear to be attached to the bone surface by 
cross-linking to the cells that are capable of attachment. The 
quantitation of membrane surface area apposed to the bone surface, 
demonstrates that the average cell surface area of con A-treated 
macrpophages that are in direct contact with the bone matrix is 
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significantly less than that of control or SBA-treated cells. The 
surface area values presented in the results were measured from SEM 
•icrographs, and therefore, are less than the actual surface areas of 
cell-matrix apposition in the unfixed state. Schneider (1976) 
demonstrated that during routine SEM tissue processing, cell 
shrinkage, due primarily to critical point drying, results in a 
greater than 50% reduction in the total cell surface area. 
45 In addition to the morphological observations, the Ca bone 
release assay was performed to evaluate the functional effects of 
con A and SBA on the macrophage-bone system. Previous studies on 
macrophage-mediated 45ca release from pre-labeled bone in vitro, have 
shown that optimal mobilization of the radioactive label requires 
cell-matrix contact (Kahn et al. 1978; Teitelbaum et al. 1979). 
Morphological studies have also demonstrated localized areas of matrix 
removal immediately underlying bone-resorbing mononuclear cells both 
in vivo (Holtrop et al. 1982) and in vitro (Kahn et al. 1978). Based 
on these studies and our own findings, we conclude that the decreased 
surface area of cell-matrix contact in the con A cultures may, at 
least in part, account for the reduction in macrophage-mediated 
mineral mobilization from these cultures. 
There also exists an important correlation between the effects of 
these 2 lectins on bone mineral mobilization by macrophages and their 
effects on 45ca release in our bone organ culture system. In previous 
studies, we have shown that con A, at a concentration of 50 pg/ml, 
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will significantly reduce the release of Ca from a pre-labeled 
bone-organ culture system, while SBA, at this same concentration, has 
00 functional effect on mineral mobilization (Popoff and Schneider 
1983; Popoff et al. 1984). The results obtained from this study 
demonstrate that con A, but not SBA, alters the morphology and 
function of macrophages on a bone surface. These findings suggest 
that cell surface and bone matrix oligosaccharides with 9'-D-glucosidic 
and c:X-D-mannosidic residues are more likely to be involved in the 
macrophage-bone interaction, than oligosaccharides with GalNAc or 
D-galactose residues. However, the possibility that membrane-bound 
con A may cause changes in cell activity and processes that play an 
important role in mineral mobilization must be assessed. Although 
there is substantial evidence that specific saccharides mediate the 
attachment of macrophages to bone, it is not yet clear how much this 
affects the function of these cells on a mineralized bone matrix. 
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Fig. 1. Control macrophages attached to a devitalized bone 
surface. The cells are in various stages of the 
spreading process (X 1000). 
Fig. 2. High magnification of control macrophages demonstrating 
numerous microvilli on the unapposed surface. Many 
filopodia as well as some larger lamellipodia are 
, present at the cell periphery (X3000). 
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Fig. 3. Con A-treated macrophages attached to bone, illustrating 
the minimal cell-matrix interaction (X 1000). 
Fig. 4. High magnification of con A-treated macrophages, as in 
fig. 3. The surface morphology demonstrates little 
evidence of cell spreading. The dorsal (unapposed) 
surface has a ruffled appearance (X 3000). 
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Fig. 5. Field of SBA-treated macrophages attached to and 
subsequently spreading on a bone surface. The SBA does 
not appear to inhibit the membrane-substrate interaction 
(X 1200). 
Fig. 6. SBA-treated cells, as in fig. 5, at a higher 
magnification. Some cells exhibit an extensive 
membrane-substrate interaction (single arrow), while 
others are less advanced (double arrows) (X 2400). 
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Fig. 7. Quantitation of macrophage attachment to bone. The 
number of con A-treated macrophages that attached to the 
bone surface is significantly greater than the number of 
control or SBA-treated cells (p( .001). 
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Fig. 8. 45 Ca bone release assay. C/C ratios; 24h (0.99 ± .02), 
48h (1.01 ± .03), 72h (0.98 :!:, .03): SBA T/C ratios; 24h 
(1.05 :!:. .06), 48h (1.00 ± .06), 72h (1.01 ± .04): con A 
T/C ratios; 24h (0.98 + .04), 48h (0.83 :!:. .07); 72h 
(0.72 + .09). 
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CHAPTER VI 
PROCESSING OF CONCANAVALIN A-RECEPTOR 
COMPLEXES BY OSTEOCLASTS IN VITRO 
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ABSTRACT 
The osteoclast is a large multinucleate cell that is widely 
accepted as the primary effector cell responsible for normal bone 
resorption. In a previous study, we demonstrated that concanavalin A 
(con A) has a dose-dependent biphasic effect on the bone resorbing 
45 
capacity of osteoclasts using a Ca bone-organ culture system; bone 
resorption was stimulated at low concentrations and inhibited at high 
concentrations. The mitogenic property of con A in lymphocyte 
cultures is well-documented, and therefore, con A has been used 
extensively to study the manner in which lymphocytes and other 
mononuclear cells process the cell-bound lectin. In this study, we 
have investigated the processing of con A-receptor complexes by 
osteoclasts in culture, using con A-FITC to evaluate the 
redistribution of cell-bound con A via epifluorescence microscopy and 
using con A-ferritin to determine whether the lectin-receptor 
complexes are internalized. The osteoclasts were obtained from the 
long bones of newborn rats and allowed to attach to glass coverslips 
at 37°c. Following attachment, the non-adherent cells were removed by 
rinsing. The adherent osteoclasts were pre-incubated in 50 pg/ml 
con A-FITC or con A-ferritin at 4°C for 10 minutes, washed to remove 
unbound con A, and incubated at 37°C for 15 or 30 minutes in the 
absence of con A. Positive controls were fixed immediately after 
0 pre-incubation at 4 C; negative controls were pre-incubated in 
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con A-FITC and o{-methyl mannoside, the haptenic inhibitor of con A 
binding. The results demonstrate that redistribution and endocytosis 
of con A-receptor complexes occurs within 30 min. These findings 
confirm the hypothesis that cell-bound con A can alter the structure 
and activity of osteoclast membrane components in a manner similar to 
that observed in mononuclear cell cultures. The internalization of 
con A may be important in altering osteoclastic activity by mediating 
intracellular mechanisms involved in the bone resorbing process. 
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INTRODUCTION 
Lectins are proteins that have been used in a variety of 
biological assays to study the surface structure and function of cells 
and tissues. Based on hapten inhibition studies which demonstrate 
that the interactions of lectins with cells can be inhibited by simple 
sugars, lectins are highly specific in their cell surface saccharide 
binding requirements (Sharon and Lis, 1972). In addition, many 
lectins exhibit differential binding affinities for various mammalian 
cells due to cell-specific differences in the expression of membrane 
glycoconjugates. These properties promote the use of lectins as 
probes to study the structure and activity of cell surface components 
in both normal and pathologically-altered tissues. In biological 
assays, lectins have demonstrated the ability to mimic the functional 
effects of documented, physiological mediators of cellular activity, 
such as hormones and lymphokines. Therefore, lectins have been used 
as in vitro model systems to evaluate the mechanisms of cellular 
activation and/or inhibition. 
A variety of agents, including certain lectins, such as 
concanavalin A (con A), phytohemagglutinin (PHA) and pokeweed mitogen 
(PWM), are capable of activating DNA and RNA synthesis in cultured 
lymphocytes (Janossy and Greaves, 1972). Subsequent to the binding of 
these mitogenic lectins, the lymphocytes undergo a sequence of 
morphological and metabolic transitions culminating in the formation 
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of blast-like cells. In addition, the mitogenic lectins are 
particularly useful since they are capable of activating cell division 
in a large, heterogeneous population of resting lymphocytes, in 
comparison to the mitogenic capacity of specific antigens that can 
only activate cell division in a small subpopulation of sensitized 
lymphocytes (Takada et al., 1983). This mitogenic property created a 
surge of interest in the use of lectins in the early 1970's, to study 
the morphological and biochemical events involved in the conversion of 
a resting cell into an active, dividing cell. 
Con A is the most widely used lectin in biological assays and its 
mitogenic property in lymphocyte cultures has been well-documented. 
Therefore, con A has been used extensively to study the manner in 
which lymphocytes process cell-bound mitogenic lectins. Studies by 
Unanue et al. (1972), Yahara and Edelman (1973) and Bhalla et al. 
(1979) have demonstrated that con A bound to lymphocyte surface 
receptors can induce patch and cap formation of its own receptor sites 
under certain conditions of incubation. The endocytosis of 
con A-receptor complexes following cap formation has also been 
described (Unanue et al., 1972; Bhalla et al., 1979). The formation 
of lectin-receptor caps and their subsequent internalization are 
metabolically dependent events (Yahara and Edelman, 1973; Ryan et al., 
1974; dePetris, 1975). It has been postulated that the processing of 
lectin-receptor complexes subsequent to lectin binding is necessary 
for mitogenic activation of lymphocytes (Taylor et al., 1971; Greaves 
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et al., 1972). 
Aside from the mechanisms involved in lectin-cell surface 
interactions, the biological effects of many lectins on a variety of 
cellular systems have been investigated both in vivo and in vitro. 
However, few studies have used lectins to evaluate the structure and 
function of the skeletal system. Wang et al. (1982) demonstrated that 
the in vivo administration of PHA-P caused a significant increase in 
the number and size of osteoclasts. Horton et al. (1982) demonstrated 
a decrease in resorption of long bones cultured in the presence of 
high concentrations of con A (50 and 100 pg/ml). Subsequent TEM of 
these con A-treated osteoclasts revealed ultrastructural changes 
associated with inhibition of osteoclastic activity (Ryder et al., 
1982). 
The studies involving the skeletal system indicate that some 
lectins can induce changes in the structure and function of bone 
cells, particularly osteoclasts. The osteoclast is a large 
multinucleate cell that is widely accepted as the primary effector 
cell responsible for normal bone resorption (Marks, 1983). Although 
the definitive origin of the osteoclast remains uncertain, there is 
abundant evidence to support the hypothesis that osteoclasts are 
derived from mononuclear cells of hemopoietic origin, possibly of the 
monocytic lineage (Walker, 1975, Marks and Walker, 1981, Schneider and 
Byrnes, 1983). In a previous study, we demonstrated that the plasma 
membrane of resident osteoclasts on the endocranial surface of rat 
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calvariae possess specific binding sites for con A (Popoff and 
Schneider, 1983). 45 In addition, we conducted a series of in vitro Ca 
bone release assays to evaluate the effect of various concentrations 
of con A on the bone resorbing capacity of osteoclasts. The bone 
mineral release assays demonstrated that con A has a biphasic effect 
on osteoclastic activity; at a low concentration (0.1 µg/ml) con A 
increased bone resorption, whereas at higher concentrations (50 and 
100 pg/ml) con A inhibited bone resorption. We concluded that con A 
may directly alter osteoclastic activity subsequent to its binding to 
specific membrane glycoconjugates. Alternately, con A may mediate 
osteoclastic activity indirectly, through the intermediary of another 
cell type. These mechanisms of action have been proposed for other 
endogenous agents that regulate osteoclastic activity (Rodan and 
Martin, 1981; Chambers and Magnus, 1982; Chambers and Dunn, 1983). 
It has been well-documented that there are a variety of agents 
that regulate osteoclast function both in vivo and in vitro. Although 
the morphological changes associated with the stimulation or 
inhibition of osteoclastic activity have been well-documented (King et 
al., 1978; Holtrop et al, 1979; Wezeman et al., 1979), the nature of 
the intracellular mechanisms responsible for these changes is poorly 
understood. Therefore, the use of an exogeneous biologically active 
agent, such as con A, in conjunction with a bone organ culture system, 
is of interest as an in vitro model to study the biological control of 
osteoclast function. Since many of the biological activities of con A 
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appear to involve the initial binding of con A to the cell surface, 
the fate of the cell-bound con A has been the focus of numerous 
investigations. In this study, we investigated the processing of 
con A-binding site complexes by osteoclasts in vitro. Con A 
conjugated to fluoresceinisothiocyanate (con A-FITC) was used to 
evaluate the redistribution of cell-bound con A via epifluorescence 
microscopy. In addition, an ultrastructural study using con A-
ferritin was conducted to determine whether these lectin-receptor 
complexes are internalized. 
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MATERIALS AND METHODS 
!,reparation of osteoclasts 
The procedure used to obtain osteoclasts from neonatal rat long 
bone is similar to that described by Chambers et al. (1984). Newborn 
Norway Hooded rats (less than 24 hr) were sacrificed and the femurs 
and tibias were removed and dissected free of soft tissue. The long 
bones were cut across at their epiphyses to separate the bony 
diaphyses from the cartilaginous ends. The four diaphyses obtained 
from each rat were then placed into shallow (2 mm) glass wells of a 
Boerner test slide containing approximately 500 ul of Medium 199 
supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin. The bones were curetted with a scalpel and the 
resulting suspension of cells and bone fragments was agitated and then 
pipetted onto a 22 mm glass coverslip using a siliconized glass 
pipette. The cells were incubated for 1 hour at 37°c. The 
non-adherent cells and bone fragments were removed by thoroughly 
washing the coverslips in 0.05M Tris buffer. The coverslips were 
examined via phase contrast microscopy and osteoclasts were identified 
on the basis of their multinucleation, since these are the only 
multinucleate cells in normal bone. This procedure yields an average 
of 80 osteoclasts per 4 long bones and a sparse population of attached 
mononuclear cells. Chambers et al. (1984) have shown that the long 
bones from newborn animals reduces the presence of contaminating 
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mononuclear cells in these osteoclast cultures, since the cellular 
component of the bone marrow is poorly developed at this age. The 
following epifluorescent (con A-FITC) and ultrastructural (con A-
ferritin) experiments were performed on the attached osteoclasts 
within a few hours. 
Phase contrast - epifluorescence microscopy 
Eight coverslips were used for this experiment. The conditions 
of incubation employed in this study have been used to study the 
redistribution of cell-bound con A-FITC in mononuclear cell cultures 
(Unanue et al., 1972; Yahara and Edelman, 1973; Bhalla et al., 1979). 
The osteoclasts were pre-incubated in 0.05M Tris buffer containing 
0 50 µg/ml con A-FITC (E-Y Labs, San Mateo, Ca.) for 10 minutes at 4 C. 
The Tris buffer used in all of our procedures was supplemented with 
O.lH NaCl and O.OlH CaC12 and adjusted to a pH of 7.2 to 7.4. To 
insure specific binding of tetravalent con A to cell surface 
glycoconjugates, both divalent calcium ions and a narrow pH range from 
7.0 to 7.4 are required (Sharon and Lis, 1972). The osteoclasts on 2 
of the coverslips were negative controls that were pre-incubated in 
50 µg/ml con A-FITC and -methyl mannoside, the haptenic inhibitor of 
con A binding. Following pre-incubation, the cells were sequentially 
rinsed to remove unbound con A-FITC molecules. After washing, the 
cells on 2 of the remaining 6 coverslips and the negative controls 
were fixed in 2.5% glutaraldehyde for 15 minutes. The osteoclasts on 
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the remaining 4 coverslips were incubated in supplemented Medium 199 
at 37°C in the absence of con A for 15 or 30 minutes prior to 
fixation. Following fixation, all coverslips were inverted and placed 
onto glycerol-coated glass slides. The osteoclasts were immediately 
examined with a Leitz Orthoplan epifluorescence microscope. 
Transmission electron microscopy 
The procedure for pre-incubation (4°C) and incubation (37°C) of 
osteoclasts with con A-ferritin was identical to that used for 
con A-FITC with the following exception. The negative controls were 
pre-incubated in 50 µg/ml native ferritin (Sigma, St. Louis, Ho.) at 
4°C for 10 minutes in the absence of con A to demonstrate the 
specificity of the conjugated ferritin label for cell-bound con A. 
Following pre-incubation in 50 µg/ml con A-ferritin (E-Y Labs, San 
0 Mateo, Ca.) at 4 C for 10 minutes, the cells were rinsed and the 
osteoclasts on 2 coverslips were fixed immediately, while the 
remaining osteoclasts were incubated in supplemented Medium 199 at 
37°C in the absence of con A for 15 or 30 minutes. Following fixation 
in 2.5% glutaraldehyde for 15 minutes, the cells were rinsed and 
post-fixed in 1% osmium tetroxide for 15 minutes. The cells were 
dehydrated through a graded series of ethanol and placed into 
propylene oxide for 2 changes at 10 minutes each. The cells were 
infiltrated in a mixture of propylene oxide and Epon 812 and embedded 
in beam capsules. After the epoxy resin polymerized, the beam 
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capsules and attached coverslips were immersed in liquid nitrogen. 
The coverslips were snapped free of the Epon capsule which resulted in 
a smooth surface on one end of the capsule containing the monolayer of 
cells. The cells were sectioned parallel to the plane of attachment. 
A single l µm thick section was cut from the smooth block face and 
stained with toluidine blue for light microscopy. Thin sections 
displaying silver or gold interference colors (60-80 nm thickness) 
were obtained using a diamond knife on an LKB Ultratome V. The 
ultrathin sections were collected on 200 mesh thin-bar grids, stained 
with uranyl acetate and lead citrate for 2 minutes each and examined 
using a Hitachi H600 electron microscope. 
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RESULTS 
Phase contrast - epifluorescence microscopy 
Osteoclasts attached to glass coverslips were easily identified 
via phase contrast microscopy on the basis of their multinucleation. 
0 Control osteoclasts that were labeled with 50 pg/ml con A-FITC at 4 C 
for 10 minutes exhibit a fluorescence that is evenly distributed over 
the entire cell surface (Fig. 1). Frequently, the fluorescence at the 
perimeter of the cell is accentuated, thereby outlining the peripheral 
extent of these attached cells (Fig. 1). A faint fluorescence over 
the filopodia extending from the periphery can also be observed. The 
negative control osteoclasts that were labeled at 4°C in the presence 
of 50 ~g/ml con A-FITC and 0.1 H ~-methyl mannoside, the specific 
inhibitor of con A-ligand binding, do not exhibit any fluorescence 
(Fig. 2). These negative controls indicate that the binding of 
con A-FITC to osteoclast membrane glycoconjugates containing «-linked 
D-glucose and D-mannose residues is specific. 
The osteoclasts that were rinsed and incubated at 37°C for 15 
minutes in the absence of con A following cold labeling with 
con A-FITC, demonstrate a localization of membrane fluorescence that 
is confined to the central, nuclear area of the cells (Fig. 3). The 
membrane peripheral to the nuclear region and the peripheral membrane 
specializations, such as lamillipodia and filopodia, showed minimal 
fluorescence. The fluorescent "caps" observed in the 15 minute 
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osteoclasts have an uneven or patchy appearance in comparison to the 
fluorescence observed on control osteoclasts. Some areas of the "cap" 
fluoresce brightly while other areas fluoresce less intensely. The 
size of the fluorescent "caps" varied depending upon the degree to 
which the cells were spread; the "caps" were smaller in those 
osteoclasts that were spread more extensively. The osteoclasts that 
0 
were rinsed and incubated at 37 C for 30 minutes in the absence of 
con A following pre-incubation with con A-FITC also exhibit a 
fluorescent pattern that is observed in the central regions of the 
cells (Fig. 4). However, in comparison to the 15 minute osteoclasts, 
the fluorescence after 30 minutes is more evenly distributed and 
occupies a larger area, thus extending further out toward the 
periphery. In addition, the negative images of the nuclei are clearly 
visible suggesting that at 30 minutes some fluorescent label is 
located in the cytoplasm of these cells (Fig. 4). 
Transmission electron microscopy 
By transmission electron microscopy (TEM), the cultured 
osteoclasts possessed many of the ultrastructural features that have 
been well-documented for osteoclasts apposed to bone in vivo (Holtrop 
and King, 1976)(Fig. 5). The nuclei in 1 um sections range in number 
from 5 to 20 per cell. Most of the nucleoplasm is euchromatic with a 
peripheral clumping of heterochromatin along the inner nuclear 
membrane. The cytoplasm is densely populated with pleomorphic 
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mitochondria. Dense bodies and vacuoles of various sizes are also 
uniformly scattered throughout the cytoplasm. Numerous investigators 
have described these dense bodies in the osteoclast and have 
associated them with the lysosomal system of the osteoclasts (Lucht, 
1972; Thyberg et al., 1975). In addition, some of the osteoclasts 
remain attached to fragments of bone surrounded by an organelle-free 
region of the cytoplasm, the clear zone (Fig. 5). 
The control osteoclasts that were pre-incubated at 4°c with 
50 pg/ml con A-ferritin exhibit an even distribution of ferritin 
particles along the entire outer leaflet of the plasmalemma (Figs. 6 & 
7). There is no evidence of internalization of the ferritin label in 
these control osteoclasts. In contrast, the osteoclasts that were 
0 0 first labeled with con A-ferritin at 4 C and then incubated at 37 C 
for 15 minutes in the absence of con A, demonstrate active endocytosis 
of the con A-ferritin receptor complexes (Fig. 8). Some areas of the 
membrane show tubular invaginations forming a system of canaliculi 
that are continuous with the cell surface (Figs. 8 & 9). 
Clathrin-coated pits are also frequently observed along the 
plasmalemma (Fig. 10). The ferritin label is concentrated in these 
caniliculi and coated pits (Figs. 9 & 10). The plasmalemma 
surrounding these membrane specializations is either devoid of label 
or sparsely labeled in an uneven fashion. In addition, some endocytic 
vesicles (endosomes) labeled with ferritin are found in the cytoplasm 
immediately underlying the cell surface (Fig. 8). Frequently, 
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channels containing the ferritin label are also observed in areas of 
the cytoplasm that do not exhibit continuity with the cell surface. 
This indicates that the canalicular system may be more extensively 
developed than is apparent from the tubular invaginations that show 
continuity with the cell surface. In the osteoclasts incubated at 
0 37 C for 30 minutes, most of the ferritin label is found in the 
cytoplasm, primarily in endosomes and occasionally in channels (Fig. 
11). The ferritin labeling density within the vesicles and the size 
of the vesicles vary considerably. Frequently, smaller endosomes 
appear to be fusing with larger ones (Fig. 11). Some of the channels 
within the cytoplasm are also continuous with the larger endosomes. 
0 Osteoclasts that were pre-incubated in 50 µg/ml native ferritin at 4 C 
in the absence of con A, do not exhibit a ferritin label along their 
cell surface. This indicates that the conjugated ferritin label is 
specific for membrane-bound con A. 
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DISCUSSION 
In the early 1970's, the mitogenic property of certain lectins, 
such as con A, PHA and PWM, created an interest in the use of these 
lectins to study blast transformation in resting lymphocyte cultures. 
Many of the ensuing investigations that focused on the morphological 
and biochemical events involved in the activation of cell division 
used con A as the lymphocyte activating agent because it offered a 
number of attractive features as a biological probe. Con A is a 
well-defined tetravalent protein that specifically binds to cell 
surface glycoconjugates containing ~-linked D-glucose and D-mannose 
residues. The haptenic inhibitor of con A binding, o<-methyl 
mannoside, is used in control cultures to demonstrate the specificity 
of con A binding to cell surface receptors. A variety of con A-
conjugates are commercially available in high purity and can be used 
to visualize membrane-bound con A via ultrastructural and cytochemical 
techniques. 
Con A is the most widely used lectin in biological assays and it 
has been used extensively to study the manner in which lymphocytes 
process cell-bound mitogenic agents. Unanue et al. (1972) used 
con A-FITC to demonstrate that patching and capping of con A binding 
0 
sites occurred when lymphocytes were labeled with con A at 4 C, then 
washed to remove unattached con A molecules, followed by incubation at 
37°c. Yahara and Edelman (1973) showed that lymphocytes incubated at 
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37°C in concentrations of con A above 10 pg/ml did not exhibit patch 
or cap formation, whereas at concentrations below 10 pg/ml some of the 
lymphocytes capped. These observations were confirmed by Bhalla et 
al. (1979), who demonstrated that if washing is omitted after 
0 pre-incubation at 4 C or if con A is added back to the medium after 
washing, the percentage of cells forming caps is drastically reduced. 
Once the caps are formed, the con A-receptor complexes are rapidly 
endocytosed (Unanue et al., 1972; Bhalla et al., 1979). The formation 
of lectin-receptor caps and their subsequent internalization are 
metabolically dependent events (Yahara and Edelman, 1973; Ryan et al., 
1974; dePetris, 1975). It has been postulated that the redistribution 
and endocytosis of cell-bound con A may be necessary events for 
mitogenic induction in lymphocyte cultures (Taylor et al., 1971; 
Greaves et al., 1972). 
The results of the con A-redistribution studies indicate that 
depending on the conditions of incubation employed, con A exhibits 2 
antagonistic properties when bound to lymphocytes; it can induce or 
inhibit cap formation of its own binding sites. To induce cap 
formation of con A-receptor complexes it is necessary to wash the 
cells following pre-incubation with con A to remove unbound con A 
molecules. In this study we have demonstrated the redistribution of 
con A-receptor complexes in cultured osteoclasts in a manner similar 
to that described for lymphocytes and other mononuclear cells. The 
osteoclasts that were pre-incubated with con A-FITC and -'-methyl 
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mannoside do not fluoresce when examined via epifluorescent 
microscopy. This indicates that the fluorescent label is specific for 
con A binding sites on the osteoclast membrane. The positive controls 
that were fixed immediately after pre-incubation with con A-FITC at 
0 4 C, exhibit a fluorescent pattern suggesting that the cell-bound 
con A is evenly distributed over the entire cell surface. When the 
cells were washed to remove the unbound con A molecules following 
0 0 pre-incubation at 4 C and subsequently wanned to 37 C for 15 minutes 
in the absence of any con A in the culture medium, the con A-binding 
site complexes had moved to occupy the membrane overlying the 
centrally located nuclei, visualized by the central localization of 
con A-FITC. This movement is similar to the fonnation of 
ligand-receptor caps in adherent mononuclear cell cultures. Although 
the intensity of the fluorescence in these osteoclast "caps" was 
greater than the intensity in the control osteoclasts, the fluorescent 
pattern within each "cap" was uneven. The cells that were washed and 
0 incubated in con A free-medium at 37 C for 30 minutes, exhibit a 
cytoplasmic localization of the fluorescent label as evidenced by the 
negative nuclear images. The cytoplasmic fluorescence observed in the 
30 minute osteoclasts suggests that the con A-receptor complexes have 
been endocytosed. 
The plasma membrane of most animal cells contains a variety of 
specific receptors for external macromolecular ligands, including 
hormones, vitamins, lymphokines and pathological agents, such as 
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bacterial toxins and viruses. Most of the surface receptors are 
glycoproteins. The induction of many of the functional effects by 
cell-specific ligands requires the internalization of the 
receptor-bound ligands. Subsequent to ligand binding, the endocytosis 
of the ligand-receptor complexes is rapid and highly specific 
(Willingham and Pastan, 1984). The general pathway of endocytosis 
involves the clustering of ligand-receptor complexes in 
clathrin-coated pits along the plasma membrane. The coated pits pinch 
off from the membrane, thus forming intracellular endocytic vesicles 
(endosomes). 
Since lectins bind specifically to cell surface glycoproteins and 
subsequently enter cells via the endocytic cycle, they have been used 
to study the mechanisms of endocytosis in cell cultures (Gonatas et 
al., 1980; Welsch et al., 1982; Welsch and Schumacher, 1983). In this 
study we used con A conjugated to ferritin to determine whether 
osteoclasts are capable of internalizing cell-bound con A. We 
performed a preliminary study to determine what concentration of 
con A-ferritin would give us a sufficient ferritin label so that we 
could accurately assess the redistribution and endocytosis of 
cell-bound con A-ferritin. From this study, we found that a 
concentration of 50 pg/ml was optimal. The control cells that were 
fixed immediately after pre-incubation at 4°C with con A-ferritin 
demonstrate a uniform ferritin label along the cell surface. The 
0 
osteoclasts that were pre-incubated at 4 C, washed and incubated at 
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0 37 C for 15 minutes exhibit a clustering of ferritin in coated pits 
and in tubular invaginations of the cell surface. In addition, 
ferritin-labeled vesicles are present in the cytoplasm subjacent to 
the cell surface. The system of canaliculi in these osteoclasts forms 
in response to the processing of cell-bound con A, since tubular 
profiles are absent in the control cells. In addition, these 
canaliculi have not been described by other investigators who have 
examined the ultrastructure of cultured osteoclasts Allen et al., 
1981; Testa et al., 1981; Suda et al., 1983). Although the continuity 
between the cell surface and some of the tubular invaginations is 
clearly evident, we frequently observed sections of ferritin labeled 
tubules that did not exhibit continuity with the cell surface. 
Therefore, the complexity of this tubular labyrinth cannot be 
determined from our ultrathin sections. Abe et al. (1981) showed that 
the examination of thick sections (1.0 - 1.5 pm) of macrophages by 
high voltage electron microscopy provides an image with 
three-dimensional features of the cell surface configuration. 
Employing this procedure to examine thick sections would enable us to 
establish the complexity of the canalicular system in these 
osteoclasts. The changes we observed in the structure and activity of 
the osteoclast membrane in this study were induced by the cell-bound 
con A and not the ferritin. This conclusion is based on the 
observation that osteoclasts pre-incubated with native ferritin at 4°C 
do not bind the ferri tin molecule. 
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0 In the osteoclasts that were incubated at 37 C for 30 minutes 
0 following the 4 C pre-incubation with con A-ferritin, the ferritin 
label is primarily located intracellularly contained within endosomes. 
Occasionally, the ferritin label is also observed within tubular 
profiles. Frequently, the larger ferritin-labeled endosomes are 
surrounded by smaller ferritin-labeled vesicles, some of which appear 
to be fusing with the larger endosomes. Although we were able to 
observe a spatial relationship between ferritin-labeled endosomes and 
the lysosomes, the lysosomal contents and the ferritin label are 
similar in density, and therefore, ferritin cannot be visualized 
within the lysosomes. To determine whether the endocytosed con A-
ferritin is ultimately routed into the lysosomes, possibly via the 
Golgi apparatus as described in some cell types, a study employing a 
different con A conjugate, such as con A-colloidal gold, should be 
conducted. 
Ultrastructural studies by Takata et al. (1984) and Abe et al. 
(1979) demonstrated that murine peritoneal macrophages possess an 
extensive three-dimensional tubular labyrinth underneath the cell 
surface. These channels are continuous with the cell surface. This 
tubular labyrinth appears similar to the tubular profiles we observed 
in the osteoclasts, with the exception that the macrophage tubular 
network even exists in cells that are not exposed to a specific 
ligand. In a recent study by Takata et al. (1984), they demonstrated 
the redistribution and endocytosis of con A-receptor complexes in 
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murine peritoneal macrophages. They labeled macrophages with 50 pg/ml 
con A-colloidal gold at 0°c, washed the cells and warmed them to 37°c. 
This resulted in the movement of con A-receptor complexes into the 
tubular network beneath the cell surface. The subsequent localization 
of colloidal gold in endosomes verified the endocytosis of con A-
receptor complexes. They concluded that the tubular labyrinth is 
involved in the processing of cell-bound con A by these macrophages. 
Since the phenomenon of capping was originally described in 1971 
by Taylor et al. on B lymphocytes in suspension, its relation to cell 
motility and the endocytic cycle has been studied on cells attached to 
a substrate. Surface receptors are cross-linked by a specific ligand 
resulting in the formation of small two-dimensional aggregates of 
ligand-receptor complexes called patches. If a cell is motile, the 
patches will move to and cap in a region of the cell membrane that is 
remote from the cell's leading edge of attachment and migration. The 
process of cap formation in migrating mononuclear cells that exhibit a 
bipolar structural organization is well documented {dePetris and Raff, 
1972; Edidin and Weiss, 1972; dePetris and Raff, 1973; Vasilieu et 
al., 1976). Bretscher {1984) described a model of membrane flow that 
relates the process of cap formation with the endocytic cycle in 
migrating cells. On the cell surface, membrane components flow from 
the cell's leading edge to the rear of the cell, the region that 
corresponds to the eventual site of cap formation. Patches of 
ligand-receptor complexes exhibit a preferential mobility resulting in 
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cap formation. The subsequent endocytosis of the capped 
ligand-receptor complexes results in a large amount of plasma membrane 
that is being internalized and must be recycled back to the cell 
surface. According to Bretscher's model, this internal membrane pool 
is transported through the cell and reinserted into the plasma 
membrane at the cell's leading edge. In this study, the osteoclasts 
are spreading evenly in all directions on the substrate, and therefore 
do not exhibit a bipolar organization. In these cells the leading 
edge occurs along the entire cell perimeter. According to the 
membrane flow hypothesis, the cross-linked con A-receptor patches 
should move away from the free edge toward the center of the cell. 
Our observations on the localization of cell-bound con A-FITC 
coincides with this hypothesis. Endocytosis of the cell-bound lectin 
results in the internalization of large amounts of plasma membrane 
which may then be transported through the cell to be reinserted at the 
leading edge. Although the phenomena of capping and endocytosis have 
been studied in relation to one another, capping of ligand-receptor 
complexes is not a necessary prerequisite for endocytosis. 
Endocytosis can occur in the absence of cap formation and it may also 
occur during cap formation. 
There are a variety of physiological agents that are capable of 
altering the bone resorbing activity of osteoclasts both in vivo and 
in vitro. These include parathyroid hormone (PTH) and calcitonin 
(CT), the two primary hormones regulating osteoclastic activity in 
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vivo. In addition studies have demonstrated that osteoclast 
activating factor, a lymphokine produced by activated lymphocytes, 
several prostaglandins, 1,25 dihydroxyvitamin n3 and interleukin-1 can 
stimulate bone resorption in vitro (Klein and Raisz, 1970; Raisz et 
al., 1972; Horton et al., 1974; Gowen et al., 1983). Some of these 
agents (i.e. CT) bind directly to specific osteoclast membrane 
receptors (Warshawsky et al., 1980; Roa et al, 1981; Chambers and 
Magnus, 1982), while others (i.e. PTH) lack specific receptors on the 
osteoclast membrane (Silve et al., 1982; Chambers and Dunn, 1983). 
These results support the hypothesis that some biologically active 
ligands may act directly on osteoclasts, while others may regulate 
osteoclastic activity indirectly through the intermediary of another 
cell type (Rodan and Hartin, 1981; Chambers and Dunn, 1983). In a 
previous study, we demonstrated specific con A binding sites on the 
osteoclast membrane (Popoff and Schneider, 1983). We also showed that 
con A has a dose-dependent biphasic effect on the bone resorbing 
45 
capacity of osteoclasts using a Ca bone organ culture system. 
The ultrastructural changes associated with the stimulation or 
inhibition of osteoclastic activity have been well-documented both in 
vivo (Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman 
et al., 1979). However, the manner in which the osteoclast processes 
ligand-receptor complexes subsequent to the binding of a functional 
ligand and the intracellular mechanisms responsible for changes in 
cell activity are poorly understood. Under the proper conditions of 
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incubation, we have shown that cell-bound con A causes an alteration 
of membrane structure and activity in cultured osteoclasts. The 
processing of con A-receptor complexes includes the redistribution and 
endocytosis of cell-bound con A in a manner similar to that described 
in a variety of mononuclear cell cultures. These metabolically 
dependent events may represent a general mechanism that is used by the 
osteoclast to process other endogenous mediators of physiological 
function that directly bind to specific membrane receptors. The 
endocytosis of ligand-receptor complexes may regulate intracellular 
events that ultimately results in an increase or a decrease in 
osteoclastic activity. 
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Fig. 1. a) Phase contrast of an osteoclast pre-incubated with 
con A-FITC at 4°C prior to fixation (X 600). 
b) corresponding fluorescent image demonstrating a 
fluorescent label that is evenly distributed over the 
entire cell surface. 
Fig. 2. a) Phase contrast of an osteoclast pre-incubated with 
0 
con A-FITC ando<-methyl mannoside at 4 C (X 600). 
b) the fluorescent image demonstrates a lack of 
.i 
lluorescent label associated with the osteoclast. 
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Fig. 3. a) Phase contrast of 2 osteoclasts pre-incubated in 
0 0 
con A-FITC at 4 C, washed, and incubated at 37 C for 
15 min {X 600). b) the fluorescent images demonstrate 
central localization of the membrane-bound label. 
Fig. 4. a) Phase contrast of an osteoclast incubated at 37°c 
for 30 min. following pre-incubation with con A-FITC 
at 4°C {X 600). b) the negative images of the nuclei 
suggest that the fluorescent label is located inside the 
lell. 
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Fig. 5. Portion of a cultured osteoclast that exhibits 
cytoplasmic features characteristic of osteoclasts. 
The cytoplasm contains many pleomorphic mitochondria, 
vacuoles and dense bodies. n - nucleus; 
ec - extracellular space; b - bone fragment; 
cz - clear zone (X 5500). 
Fig. 6. Cell surface of an osteoclast pre-incubated with 
con A-ferritin prior to fixation. The ferritin label is 
evenly distributed along the outer aspect of the plasma 
membrane (X 40,000). 
i 
Fig. 7. 'High magnification of the cell membrane of a control 
osteoclast. This tangential section demonstrates the 
even distribution of ferritin particles (X 80,000). 
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Fig. 8. Portion of an osteoclast incubated at 37°c for 15 min 
0 
after pre-incubation with con A-ferritin at 4 C. The 
ferritin label at the cell surface is concentrated in 
the tubular invaginations of the plasmalemma. There are 
also some ferritin-labeled endocytic vesicles (arrows) 
within the cytoplasm (X 40,000). 
Fig. 9. High magnification of a tubular invagination from the 
osteoclast in Figure 8, demonstrating the localization 
of the ferritin label (X 120,000). 
Fig. 10 High magnification of a coated pit at the surface of a 
1! min. osteoclast. The ferritin label is confined to 
the coated pit area, while the surrounding membrane is 
free of label (X 120,000). 
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Fig. 11 Cytoplasm of an osteoclast incubated at 37°c for 30 min. 
0 
after con A-ferritin pre-incubation at 4 C. Ferritin-
labeled endosomes of various sizes {solid arrows) and 
occasional ferritin-labeled tubules {open arrows) are 
present in the cytoplasm {X 50,000). 
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CHAPTER VII 
DISCUSSION 
Lectins have been used in a variety of biological assays to study 
the surface structure and function of cells and tissues. However, few 
studies have used lectins to evaluate the structure and function of 
the skeletal system. Wang et al. (1982) demonstrated that the in vivo 
administration of PHA-P caused a significant increase in the number 
and size of long bone osteoclasts. Horton et al. (1982) demonstrated 
a decrease in resorption of long bones cultured in the presence of 
high concentrations of con A (50 and 100 µg/ml). Subsequent TEM of 
these con A-treated osteoclasts revealed ultrastructural changes 
associated with inhibition of osteoclastic activity (Ryder et al., 
1982). 
The studies involving the skeletal system indicate that some 
lectins are capable of inducing changes in bone cells, particularly 
osteoclasts. Therefore, we were initially interested in demonstrating 
the existence of specific con A binding sites on the surface of 
osteoclasts and in evaluating the functional effects of various 
concentrations of con A on bone resorption and osteoclastic activity. 
For these studies we used the calvariae of 10-day old rats for the 
following reasons. The distribution of osteoclasts and osteoblasts on 
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the endocranial surface of the flat bones of the growing rodent skull 
is well-documented and the number of osteoclasts reaches its peak at 
approximately 10-days post-partum (Barnicott, 1947; Jones and Boyde, 
1976; Jones and Boyde, 1977; Abe et al., 1983). In addition, the 
culture of these calvarial bone-organ explants is a resorbing culture 
system that can be used as an in vitro model to quantitatively 
evaluate the functional effects of con A on resident osteoclasts 
attached to their natural substrate. 
The culture of bone-organ explants such as calvariae is an organ 
culture system in which the resorption of bone occurs without the 
addition of any stimulating agents. The fetal bovine serum that is 
used to supplement the tissue culture medium contains a variety of 
serum components, some of which are probably capable of influencing 
osteoclastic bone resorbing activity. The release of 45ca from 
pre-labeled calvariae can be quantitated with respect to the total 
45 
amount of Ca initially present in each calvaria, yielding the 
45 percent of Ca released over a specified period of time. The average 
percent 45ca release from calvariae that have been devitalized and 
cultured in BGJb medium for a period of 72 hrs. (dead bone release) is 
3.1 .± 0.4% (fig. 1). 45 In comparison, the average percent Ca release 
from live calvarial explants cultured under identical conditions for 
72 hrs. (live bone release) is 11.2 .± 0.6% (fig. 1). The difference 
of approximately 8.2% is due to the resident cellular component which 
is eliminated from the calvarial explants by devitalization. The 
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cellular component is primarily composed of the 3 bone cell types: 
namely osteoclasts, osteoblasts and osteocytes. Other mononuclear 
cells, such as macrophages and periosteal fibroblasts, also constitute 
a small fraction of the cells present in normal calvariae. The 
osteoclast is widely accepted as the primary effector cell responsible 
for normal bone resorption (Harks, 1983). Therefore, the osteoclasts 
45 
are largely responsible for the cell-mediated Ca release in the live 
bone-organ cultures. However, the other resident cells are also 
45 
capable of mobilizing Ca and they may also contribute to the overall 
45 
release of Ca from the live bone-organ cultures. (Rodan and Hartin, 
1981; Hamilton et al., 1984; Heath et al., 1984; Otsuka et al., 1984). 
Using con A and hemocyanin, a marker molecule used to visualize 
cell-bound con A via SEH, we demonstrated that resident calvarial 
osteoclasts have specific binding sites for con A on their cell 
surface. The specificity of these con A receptors was determined by 
using ~-methyl mannoside, the haptenic inhibitor of con A binding, in 
control cultures. A series of 45ca bone release assays were conducted 
using pre-labeled calvariae to determine whether or not con A, at 
45 
various concentrations, has any effect on Ca release. The ability 
45 
of osteoclasts to resorb bone was determined by the amount of Ca 
released into the tissue culture medium during three 24 hr. periods 
after the release of labile 45ca. The results demonstrate that con A 
has a dose-dependent biphasic effect on the bone resorbing capacity of 
osteoclasts; at a low concentration (0.1 µg/ml) con A increased bone 
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resorption, whereas at higher concentrations (50 and 100 pg/ml) con A 
inhibited bone resorption. We also showed that the con A-mediated 
reduction in the release of 45ca at 50 pg/ml is reversible, indicating 
that con A is inhibitory rather than cytotoxic to osteoclasts at the 
higher concentrations. 
After observing the effects of con A, we were interested in the 
45 
effects of three other lectins, WGA, SBA and PNA, on Ca release in 
the calvarial culture system. The four lectins, con A, WGA, SBA and 
PNA, have cell surface saccharide binding specificities that are 
distinctly different from one another. All of the sugar residues to 
which these four lectins bind are common to mammalian 
membrane-associated glycoconjugates. Another series of 45 ca bone 
release assays were performed using a lectin concentration of 50 pg/ml 
for each of the three lectins to be tested. At this concentration, 
WGA inhibited the release of 45ea, although its effect was not as 
pronounced as that of con A at the same concentration. On the 
contrary, neither SBA nor PNA had any effect on bone resorption in 
comparison with the control assay run in the absence of any lectin. 
These findings indicate that the reduction in bone resorption mediated 
by con A, and to a lesser extent WGA, at a concentration of 50 pg/ml 
is not a generalized phenomenon that occurs subsequent to the binding 
of any lectin at this concentration. This conclusion would suggest 
that the specificity of lectin binding to cell surface receptors is an 
important factor in the induction of an alteration of cellular 
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function that is mediated by a particular lectin. 
There are a variety of agents that regulate osteoclastic activity 
in vivo and in vitro. These include the two primary hormones that 
regulate osteoclastic function in vivo, PTH and CT. In vitro a 
variety of agents influence the ability of osteoclasts to resorb bone, 
including the vitamin l,25(0H) 2n3 , several prostaglandins, and the 
lymphokines OAF and IL-1. Numerous investigators have probed the 
osteoclast membrane to determine whether or not specific receptors for 
PTH and CT are present (Warshawsky et al., 1980; Rao et al., 1981; 
Chambers and Dunn, 1982; Chambers and Magnus, 1982; Silve et al., 
1982; Chambers and Moore, 1983). The results of these studies support 
the hypothesis that some agents may act directly on osteoclasts (i.e. 
CT), while others may regulate osteoclastic activity indirectly (i.e. 
PTH) through the intermediary of another cell type (Rodan and Martin, 
1981; Chambers and Dunn, 1983). Although the ultrastructural changes 
associated with the stimulation or inhibition of osteoclastic activity 
have been well-documented both in vivo (Holtrop and King, 1976; 
Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman et al., 
1979), the mechanisms responsible for changes in osteoclastic activity 
are poorly understood. Functional ligands that directly bind to 
specific membrane receptors and subsequently alter cellular activity 
can do so via two general mechanisms; the cell-bound ligand can 
regulate cell function through an alteration of the cell surface 
structure or the cell-matrix interaction (external mechanism), or the 
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ligand-receptor complexes can be internalized (internal mechanism). 
The external mechanism whereby a ligand can regulate a cellular 
activity includes the following possiblities. The binding of a 
particular ligand to specific membrane receptors can either enhance or 
inhibit the binding of another functional ligand to the cell surface. 
In the con A-treated bone-organ culture system this is possible since 
the tissue culture serum supplement contains a variety of components, 
some of which are probably capable of regulating osteoclastic 
function. The ability of a particular ligand to influence the binding 
of another functional ligand can only be evaluated in a culture system 
in which all of the components of the culture medium are defined. On 
the other hand, in tissue and organ culture systems where a 
morphological and functional interaction between the cells being 
studied and the matrix to which the cells are attached is essential 
for normal cell function, a cell-bound ligand may modify the 
cell-matrix interaction thereby altering cell function. 
It is well-documented that there is a morphological and 
functional interaction between the osteoclast and the bone matrix that 
f 
is esential for normal resorptive activity to occur. The clear zone 
and ruffled border membrane specializations apposed to the bone matrix 
are the ultrastructural hallmarks of active osteoclastic bone 
resorption. We were interested in evaluating the effects of 2 
lectins, con A and SBA on the interaction between the osteoclast and 
the bone matrix. However, this type of experiment is technically 
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impossible for a number of reasons. The procedure would involve the 
isolation of a pure population of osteoclasts in large numbers. No 
one to date has successfully isolated a pure population of 
osteoclasts. If it were possible to isolate osteoclasts in large 
numbers the cells would then be treated with either con A or SBA and 
allowed to attach to a devitalized bone surface. However, osteoclasts 
are extremely sensitive to any type of mechanical trauma and the 
manipulation of thse cells required in this type of experiment would 
probably result in cell death. Even if it were possible to establish 
a viable pool of osteoclasts attached to a devitalized bone surface, 
the maintenance of these cells in long term culture and the ability to 
quantitatively assess their capacity to resorb bone is, at best, 
questionable. 
Because of the difficulty in obtaining pure populations of 
osteoclasts, most studies on bone resorption are performed on intact 
animals or bone-organ cultures. These sytems do not permit detailed 
analysis of cellular mechanisms of bone resorption or of the means 
whereby resorbing cells attach to the bone surface (Teitelbaum et al., 
1979). Since monocytes and macrophages are capable of attaching to 
and subsequently resorbing devitalized bone in vitro (Mundy et al., 
1977; Kahn et al., 1978; Teitelbaum et al., 1979), the 
macrophage-devitalized bone culture system serves as a useful model to 
study the morphological and functional interaction between the 
resorbing macrophages and the bone matrix. The studies by Kahn et al. 
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(1978) and Teitelbaum ~t al. (1979) also demonstrated that optimal 
macrophage-mediated mineral mobilization requires cell-matrix contact. 
Recent studies by Bar-Shavit et al. (1983b,c,d) have demonstrated that 
the attachment of macrophages to bone is a regulated process that is 
mediated, in part, by certain saccharides located on the cell and/or 
bone surfaces. These findings indicate that the attachment of 
resorbing macrophages to the bone matrix is an important component of 
the process of bone resorption and that the oligosaccharide-mediated 
binding mechanism that links the resorbing macrophages to bone is 
essential for normal resorptive activity. 
The importance of the cell-matrix interaction in the 
macrophage-bone culture system justifies its use to evaluate the 
effects of con A and SBA on the interaction between a bone matrix and 
cells that are capable of attaching to and subsequently degrading it. 
45 We chose these 2 lectins based on the results from the Ca bone 
release assays in which con A at a concentration of 50 pg/ml inhibited 
bone resorption, whereas SBA had no effect on bone resorption at the 
same concentration. The results demonstrate that macrophages allowed 
to attach to bone in the presence of con A exhibit a cell surface 
morphology that is markedly different from that of control macrophages 
as visualized by SEM. Although the con A-treated macrophages do 
attach to the bone surface, they are hindered in their ability to 
spread on the substrate. The membrane surface area that is apposed to 
the bone surface in the con A-treated system is only one-half that of 
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control cells. The quantitative results demonstrate that 
approximately twice the number of con A-treated macrophages attached 
to the bone surface in comparison with the number of untreated cells. 
45 Although these results seem to conflict with the Ca functional data, 
this quantitative difference is most likely the result of the 
extensive aggregation of macrophages by con A. The cross-linking of 
cell membranes by con A may significantly increase the number of cells 
that appear to attach to the bone matrix, since those cells that would 
not attach under normal conditions appear to be attached to the bone 
surface by cross-linking to the cells that are capable of attachment. 
On the contrary, SBA does not appear to change the attachment and 
subsequent spreading of macrophages on bone either morphologically or 
quantitatively. 
45 A series of Ca bone release assays were conducted to determine 
whether the morphological observations could be correlated to any 
functional differences in the ability of con A-treated or SBA-treated 
macrophages to release 45ca in vitro. The con A-treated 
macrophage-bone samples demonstrated a significant decrease in mineral 
45 
mobilization at 48 and 72 hours, whereas the Ca released from the 
macrophage-bone samples in the presence of SBA did not differ 
significantly from the control assay at any of the sampling time 
points. 
The results obtained from this macrophage-devitalized bone 
culture system demonstrate that con A, but not SBA, alters the 
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morphology and function of macrophages on a bone surface. The 
morphological findings support the hypothesis that specific 
saccharides common to cell surface and/or matrix associated 
glycoconjugates are involved in the macrophage-bone interaction. 
Oligosaccharides containing ..(-linked D-glucose and D-mannose residues 
are more likely to be involved in the macrophage-bone interaction, 
than oligosaccharides containing GalNAc or D-galactose residues. The 
functional data suggest that the decreased surface area of cell-matrix 
contact in the con A-treated cultures may, at least in part, account 
for the reduction in macrophage-mediated mineral mobilization. 
There also exists a correlation between the effects of con A and 
SBA on bone mineral mobilization in the macrophage-bone cultures and 
45 their effects on Ca release in the bone-organ cultures. At the 
lectin concentration of 50 pg/ml, con A causes a reduction in the 
release of 45ca in both systems, whereas SBA has no effect on mineral 
mobilization in either system. In both culture systems, cell-matrix 
contact and the subsequent functional interaction are important 
components of the process of bone degradation. Therefore, it is 
possible that the con A-mediated inhibition of bone resorption in the 
bone-organ culture system at higher concentrations may, in part, be 
the result of the ability of cell-bound con A to interfere with the 
interaction between the osteoclast and the bone matrix, an essential 
prerequisite for normal resorptive activity. 
When comparing these 2 culture systems it is important to use the 
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term "resorption" corre.c tly. The regulated process of normal bone 
breakdown by osteoclasts is called bone resorption. The ruffled 
border and clear zone are ultrastructural hallmarks indicative of 
active resorption of underlying bone by osteoclasts. Although there 
are similarities in the degradation of bone by macrophages, the 
development of clear zones and ruff led borders have never been 
demonstrated in the macrophage-bone culture system. Therefore, when 
referring to macrophage-mediated bone breakdown terms such as mineral 
mobilization and bone degradation should be used and the word 
"resorption" should be limited to the process mediated by osteoclas ts. 
The induction of many of the functional effects by cell-specific 
ligands requires the internalization of the cell-bound ligands. The 
internal mechanism that was alluded to earlier in this discussion 
involves the processing of ligand-receptor complexes, including the 
redistribution and endocytosis of these complexes. Once the ligand 
has been internalized it can follow a variety of intracellular 
pathways thereby influencing one or more intracellular events that 
will ultimately result in altered cell function. A general summary of 
the events related to receptor mediated endocytosis is schematically 
presented in fig. 2. Subsequent to ligand binding to specific 
membrane receptors, the ligand-receptor complexes become clustered in 
coated pits along the membrane. These coated pits have a 
clathrin-protein coat attached to the inner leaflet of the 
plasmalemma. The coated pits pinch off from the cell surface forming 
162 
endocytic vesicles (endosomes) that rapidly lose their protein coat 
which is recycled back to the cell surface. The endosomes migrate 
deeper into the cytoplasm and frequently fuse with one another. At 
some point along the intracellular pathway, the ligand-receptor 
complex is dissociated and the receptors are usually recycled back to 
the surface. The intracellular routing of a particular ligand and the 
ultimate localization of that ligand within a specific subcellular 
compartment depends on the type of ligand that has been internalized. 
The lysosomal system, nucleus and Golgi apparatus are frequent sites 
of ligand localization. 
Since many of the biological activities of con A appear to 
involve the initial binding and subsequent processing of cell-bound 
con A, the fate of the con A-receptor complexes has been investigated 
in a variety of mononuclear cell cultures. The mitogenic property of 
con A in lymphocyte cultures is well-documented, and therefore, the 
manner in which lymphocytes process cell-bound con A has been studied 
extensively. Studies by Unanue et al. (1972), Yahara and Edelman 
(1973) and Bhalla et al. (1979) demonstrated that con A bound to 
lymphocyte surface receptors can induce patch and cap formation of its 
own receptors under certain conditions of incubation. The endocytosis 
of con A-receptor complexes following cap formation has also been 
described (Unanue et al., 1972; Bhalla et al., 1979). The capping and 
endocytosis of ligand-receptor complexes are metabolically dependent 
events (Yahara and Edelman, 1973: Ryan et al., 1974; dePetris, 1975). 
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It has been postulated that the processing of ligand-receptor 
complexes in these lymphocyte cultures is necessary for mitogenic 
activation of lymphocytes (Taylor et al., 1971; Greaves et al., 1972). 
Since the phenomenon of capping was originally described in 1971 
by Taylor et al. on B lymphocytes in suspension, its relation to cell 
motility and the endocytic cycle has been studied in a variety of 
substrate-attached mononuclear cells (dePetris and Rff, 1972; Edidin 
and Weiss, 1972; Vasilieu et al., 1976). We investigated the 
processing of con A-receptor complexes by osteoclasts in culture, 
using con A-FITC to evaluate the redistribution of cell-bound con A 
via epifluorescence microscopy and using con A-ferritin to determine 
whether the lectin-receptor complexes are internalized via electron 
microscopy. The results demonstrate that redistribution and 
endocytosis of con A-receptor complexes occurs within 30 minutes. In 
comparison to control osteoclasts that exhibit a fluorescent pattern 
which is evenly distributed over the entire cell surface, after 15 
minutes the fluorescence is localized to the membrane overlying the 
central, nuclear region of the substrate-attached osteoclasts. The 
membrane peripheral to the nuclear region and membrane specializations 
such as filopodia and lamellipodia were cleared of the fluorescent 
label. The redistribution of membrane-bound con A-FITC on 
substrate-attached osteoclasts is similar to the movement of con A-
FITC on substrate-attached epithelial cells and fibroblasts described 
by Vasilieu et al. (1976). Electron microscopy of con A-ferritin 
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treated osteoclasts revealed active endocytosis of the con A-receptor 
complexes. The ferritin label is concentrated in coated pits and in 
tubular invaginations of the cell surface (fig. 2). The tubular 
vaginations found along some areas of the membrane form a system of 
canaliculi that are continuous with the cell surface. These tubular 
invaginations are membrane specializations that form in response to 
the binding and processing of con A, since they are absent in control 
osteoclasts. The internalization of con A may be an important event 
in altering osteoclastic activity by mediating intracellular 
mechanisms involved in the bone resorbing process. Our findings 
confirm the hypothesis that cell-bound con A can alter the structure 
and activity of osteoclast membrane components in a manner similar to 
that observed in some mononuclear cell cultures. The redistribution 
and endocytosis of con A-receptor complexes may represent a general 
mechanism that is used by the osteoclast to process other endogenous 
mediators of physiological function that directly bind to specific 
membrane receptors. 
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Fig. 1. 45 The percent of Ca released at 24 hour intervals in 
cultures of live calvarial explants versus devitalized 
bone. Live bone percent release: 24 hr= 4.7 ± 0.3; 
48 hr • 8.2 ± 0.5; 72 hr = 11.2 + 0.6. Dead bone 
percent release: 24 hr= 1.3 + 0.3; 48 hr= 2.2 + 0.2; 
72 hr • 3.1 + 0.4. 
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Fig. 2. Diagram showing some of the general events that occur 
as a part of the endocytic mechanism following ligand 
binding to specific surface receptors (right side of 
broken line). To the left are the membrane 
specializations (tubular invaginations) that we 
demonstrated on the surface of osteoclasts processing 
cell-bound con A in vitro. 
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Appendix to Chapter III 
Discussion with Reviewers 
T.J. Chambers: The authors should give some idea of the counts per 
minute upon which their bone resorption assay figures are based. 
S.C. Harks: The calcium-45 release data might be even more 
significant if younger (newborn vs. 7 day old) rats and higher doses 
(50-100 vs. 40 pCi) of calcium-45 were used. This would have made the 
assay even more sensitive. 
Authors: The data presented in Table 1 demonstrates some typical 
values of radioactivity in counts per minute (cpm) generated from a 
200 pl sample of tissue culture supernatant at 48 hours. The value 
generated by a treated calvarial half is shown above the value 
generated by the corresponding control half. Values for two calvarial 
samples at each of the four concentrations of con A are4 ~hown. The 
relatively high counts validate the sensitivity of our Ca bone 
release assay. 
T.J. Chambers: What is the contribution of con A toxicity to 
osteoclastic inhibition as demonstrated in this paper? 
H.H. Hiller: How do you propose to distinguish between inhibition of 
cytotoxicity at high concentrations of con A? 
Authors: To determine whether the decrease in bone resorption at 50 
pg/ml con A is due to con A induced inhibition of osteoclastic 
activity or whether this high conczgtration is merely cytotoxic to 
osteoclasts, we conducted another Ca bone release assay. The 
experimental protocol was identical to that which has already been 
described in the text, with the exception that the media containing 
con A was removed from the treated wells after 12 hours. These wells 
were then rinsed and replenished with fresh media in the absence of 
any con A. After 12 c~urs of incubation in 50 pg/ml con A, the 
decreased release of Ca from treated calvarial halves was 
significantly different from that of control calvarial halves (fig. 
1). 24 hours after con A was removed, the mean T/C ratio returned to 
1.0 and this reversal continued at 48 hours (fig. 11). We also took a 
sample 120 hours after con A removal and this preliminary data 
suggests that we have a rebound effect on bone resorption. This 
result showing that the decrease in bone resorption at 50 pg/ml is 
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reversible, indicates that con A is inhibitory rather than cytotoxic 
to osteoclasts at this concentration. 
45 S.C. Marks: The significance of the differences between Ca release 
at the lowest concentration of con A and the concentration {2.0 µg/ml) 
with peak mitogenic activity is puzzling. That the former is higher 
than the latter sugget5s that lymphokine production is probably not 
involved in elevated Ca release. 
Authors: We agree with this conclusion and furthermore evaluated the 
calvarial samples to determine the extent of cells present in the 
culture system that could produce lymphokines. The calvarial samples 
mere digested with collagenase and the cellular pools evaluated for T 
lymphocytes, B lymphocytes, monocytes and macrophages, utilizing 
fluorescence microscopy and fluorescein-conjugated antibodies directed 
against specific cell surface markers. The calvarial system did not 
contain enough cells to produce significant amounts of lymphokines. 
T.J. Chambers: The bidirectional effect of con A suggests that there 
may be both a direct and an indirect effect on osteoclastic activity. 
Have you tested these possibilities using isolated osteoclasts? Has 
anyone reported an effect of con A on osteoblast activity? 
Authors: We have been unable to isolate a homogeneous population of 
osteoclasts which could be tested in vitro. The osteoclast isolate 
always contains mononuclear cells which may include lymphocytes and 
osteoblasts, both of which are known to be able to influence 
osteoclasts. We plan to evaluate the effelts of con A on osteoblast 
activity by monitoring such parameters as H-proline incorporation, 
alkaline phosphatase levels and cAMP levels. 
R.S. Molday: Have you studied the effect of con A concentration on 
the density and distribution of binding sites using the hemocyanin 
method? 
Authors: We have only looked at con A binding at the concentration of 
100 pg/ml. The hemocyanin particles appear densely packed at this 
concentration and may be causing steric hindrance. The density and 
distribution of binding sites at different concentrations of con A 
should be studied using a smaller marker and a TEM as well as an SEM 
evaluation. 
S.C. Marks: What is the functional significance of con A binding? 
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That a lectin would bind to the surface of an animal cell might not be 
surprising. That this represents some specific receptor site remains 
to be determined. We know of no evidence that these cells encounter 
con A in vivo. Therefore, other than the fact that certain 
carbohydrate moieties appear to be uniformly distributed on the 
external surface of osteoclasts and osteoblasts, what does con A 
binding mean? Can one make a case for its physiological significance 
in bone? 
Authors: We are using lectin binding and its stimulatory and/or 
inhibitory effects as a model system for osteoclasts, much the same as 
other investigators have used lectins to activate lymphocytes and 
initiate their proliferation. Although the activation may be quite 
non-specific, the way in which the lectin is handled by the cell, 
i.e., the possible redistribution and endocytosis of binding sites, 
may give some insight into the mechanisms by which physiologically 
active substances exert their effects on bone cells. 
H.H. Hiller: What are those fibrous structures associated with the 
osteoblasts and would you comment on the apparent association of con 
A-hemocyanin with them? 
Authors: The fibrous structures are collagen fibrils. The con 
A-hemocyanin is binding to the mannosyl and glucosyl residues of the 
glycosaminoglycans associated with the collagen. 
S.C. Harks: Is it possible that reduced calcium-45 release observed 
with high doses of con A is caused by activation of the calcitonin 
receptors through a local distortion of the osteoclast membrane by the 
high density binding of con A? If so, one might not be surprised if a 
measurement of bone formation at this dose were also affected. 
Authors: We plan to investigate the fate of the con A binding sites 
at various time intervals after treatment with the lectin. If the 
binding sites demonstrate redistribution, then this movement may cause 
the local distortion that you suggest. We are going to evaluate 
osteoblastic activity at Jll of the concentrations originally tested 
via the incorporation of H-proline. 
H.H. Hiller: 45 How do you imagine that con A stimulates Ca release? 
Authors: In order to approach this question we have to study the fate 
of the con A-binding site complexes at various time intervals after 
treatment. Is there redistribution of plasma membrane components; is 
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the con A internalized by the bone cells; and is this internalization 
necessary for stimulatfon? 
R.S. Molday: In control labeling experiments, o(-methyl mannoside was 
successfully used to reverse the labeling of cells with con A. Why 
doesn't the hemocyanin also compete with the cell binding sites and 
cause the con A to dissociate? 
Authors: o(-methyl mannoside competes for the same sites by which con 
A binds to cell surface macromolecules. Since Q('.~methyl mannoside has 
a much greater affinity than cell surface glucosyl and mannosyl 
residues for the same sites on the con A molecule, con A dissociates 
from the cell surface when a-methyl mannoside is present in the 
culture media. Hemocyanin, on the other hand, binds to sugar residues 
on the con A molecule which are structurally different than those 
involved in cell surface binding and, therefore, does not compete with 
cell surface binding sites. 
Table 1 45ca Bone Release Assay 
CPM at 48 Hours 
con A ( o. l µg/ml) 2550* 
------------------------- ---------------
control 1867 
con A (2.0 µg/ml) 2007 
------------------------- ---------------
control 1823 
con A ( 50 µg/ml) 1219 
~------------------------- ---------------
control 1948 
con A (100 µg/ml) 1165 
~------------------------- ---------------
control 2066 
I 
1922 
---------------· 
1533 
1471 
---------------· 1569 
1056 
---------------1655 
1153 
---------------2149 
*counts per minute generated from a 200 µl 
sample of tissue culture supernatant 
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Fig. 1. Reversal of con A-mediated inhibition of bone resorption. 
The mean T/C ratio is plotted on the y-axis and the time of 
sampling on the x-axis. The numbers in parentheses 
represents the time of sampling following con A removal 
(indicated by arrow), whereas the number above represents 
the totf! time in culture following the 24 hour washout of 
labile Ca. 
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This appendix supplements the data presented in Chapter IV. 45 ca 
bone release assays were conducted to determine the effect of wheat 
germ agglutinin (WGA), soybean agglutinin (SBA) and peanut agglutinin 
(PNA) on bone resorption. The data presented in Chapter IV only 
includes the treated/control (T/C) ratios4!or each lectin at a 
concentration of 50 µg/ml. However, the Ca bone release assays were 
conducted at 2 or more concentrations for each of the lectins tested. 
The following table lists the mean T/C ratios at 24, 48 and 72 hours 
for all concentrations tested. The T/C ratios were compared to the 
control/control (C/C) ratio obtained from the control release assay to 
determine whether the observed changes in bone resorption were 
significantly different. Significance was evaluated by a two-tailed 
Student t-test for the difference between two means. 
Table 1 
Lectin 
WGA 
SBA 
PNA 
* 
Effects of various 
Concentration 
0.1 
1.0 
10 
50 
50 
100 
1.0 
10 
50 
(µ g/ml ) 
lectins on bone resorption 
24 hr. 
1.08 ± .06 
1.06 ± .06 
1.01 ± .09 
0.95±.09 
0. 98 ± .06 
1.00 ± .04 
1.00 ± .03 
1.03 ± .03 
1.01 ± .08 
Significantly different from control assay (p < .001) 
T/C ratios 
48 hr. 
1.06 ± .04 
1. 03 ± . 05 
0.95 ± .06 
*0.84 ± .05 
0.96±.07 
0.98 ± .02 
1.01 ± .02 
0.96 ± .06 
0.97 ± .01 
72 hr. 
1.09 :t .05 
1.05 ± .04 
o. 95 ± .09 
*O. 71 ± .04 
0.97 ± .06 
0.97 ± .03 
1. 01 ± . 06 
1.01 ± .05 
0. 94 ± .06 
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